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Phenoloxidase, the integral enzyme for the prophenoloxidase cascade system 
in insects and crustaceans is essential in the melanization of pathogens and wound 
healing.  Upon proteolytic activation of the zymogen prophenoloxidase, the active 
enzyme phenoloxidase catalyzes phenol substrates to sclerotize the protein matrix of 
arthropod cuticles.  The hard exoskeleton protects and supports the body of 




crustaceans must periodically molt by shedding their exoskeletons (ecdysis).  Ecdysis 
is triggered by the action of a set of hormones, which also initiate the previous 
deposition of a new soft cuticle beneath the hard exoskeleton.  The flexible and soft 
new cuticle is expanded by the isosmotic intake of water during and immediately 
after ecdysis.  Animals can then display their molt-related somatic growth.  At the 
same time the unarmored crustaceans undergo the concurrent shell-hardening process 
to build a new exoskeleton.   
In crustaceans, the molecular and physiological mechanisms involved in the 
initial shell hardening process have been poorly understood compared to the 
corresponding process in insects.  This dissertation addresses the molecular 
mechanisms which regulate the initial shell-hardening process of crustaceans, using 
the blue crab Callinectes sapidus as research model.  To this end, the research focuses 
on the hemocyte prophenoloxidase and the neurohormone bursicon to define their 
roles and interactions in the regulation of the initial shell-hardening.  A differential 
expression of prophenoloxidase in hemocytes is found and the role of 
prophenoloxidase in the shell-hardening process of crustacean is established. 
Unraveling the shell-hardening process of C. sapidus will add our understanding of 
the molt-related somatic growth of this and other economically valuable decapod 
crustacean species.  This knowledge may contribute to increases in productivity of 
crustacean fisheries and aquaculture by the development of biotechnology to extend 
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Crustaceans, as do all arthropods, undergo the molting process repeatedly 
during their lifespan to complete their growth, sexual maturation and reproduction 
[1,2].  Molting is a cycle that involves the synthesis of a new soft cuticle beneath the 
hard exoskeleton.  Next, the exoskeleton needs to be shed during a step called ecdysis 
to expand the new pliable cuticle and reach the somatic growth [1,2].  Several 
physiological pathways, such as cuticle deposition, calcium and protein reabsorption, 
and osmotic intake of water, must work in coordination to have successful ecdysis 
[3,4].  This physiological coordination is hormonally controlled through  interactions 
among hormones and neurohormones and determine different molt cycle stages [3–
10].  After ecdysis, the new soft cuticle needs to be transformed quickly into a hard 
exoskeleton to recover mobility, body support, defense and feeding capabilities that 
the hard external armor confers to arthropods.  The physiological pathways that 
activate this transformation are called the shell-hardening  process [11–17].  
The shell-hardening process in crustaceans involves two sequential processes, 
beginning with the sclerotization  of the new cuticles and ending with  mineralization, 
the incorporation of calcium carbonate into the cuticle [11,12,14,15,17,18].  The 
sclerotization occurring in the two first layers of the cuticle is mediated by the 
enzymatic reaction of phenoloxidases (POs) that catalyze phenols as a substrate to 
cross-link chitin and protein fibers [2,11,18].  In crustaceans, unlike insects, this 




POs are copper binding enzymes that catalyze the hydroxylation of 
monophenols or the oxidation of diphenols to the correspond quinones, or both [19–
21].  Multiple forms of POs are found in several arthropod species [17,21–32].  In 
insects such as Nephotettix cincticeps, Tribolium castaneum, Calliphora vicina, and 
Bombyx mori the sclerotization process is complex and POs and other enzymes act in 
concert to stiffen the new cuticle: tyrosinases, laccases, tyrosine hydroxylases, and 
peroxidases seem to be part of the whole insect sclerotization system 
[12,17,21,25,31,33–35].  Tyrosinases are known with the general name of 
prophenoloxidase (PPO), the zymogen form that is activated into the functional PO 
by the action of serine proteases (prophenoloxidase activating enzymes) [26,36].  In 
crustaceans, it is believed that the PPOs expressed in hemocytes initiate the shell-
hardening process [37,38].  This PPO is an essential component of the innate 
immunity system of crustaceans involved in melanization, blood coagulation, 
encapsulation of pathogens, and wound healing [39–43]. 
Only PPOs have been characterized in crustaceans [44–47] and the presence 
of laccases remains to be confirmed.  Tyrosine hydroxylases have been reported in 
crustaceans, but unlike insects, they have not been directly associated with the shell-
hardening process [48–53]. 
Hemocyte aggregations are found in the connective tissues just below cuticle 
and underneath the crustacean  hypodermis specifically during  premolt and ecdysis 
[37,38].  Hence it has been suggested that the hemocyte PPO may be transported into 
the hypodermis during early premolt and ecdysis, to initiate the shell-hardening of the 




insects [25,30].  A trans-epithelial transporter system mobilizes the insect PPO from 
the hemolymph into the hypodermis to be localized later into the cuticle [25].  In 
crustaceans, however, the transport of hemocyte PPO into the new cuticle has not yet 
been examined. 
Based on the information presented, it is possible to consider that a 
coordinated series of events needs to occur to reach the shell-hardening process.  The 
precise timing of each event is essential and should be addressed below a major 
control.  In insects, the cuticle hardening involves sclerotization and melanization, a 
process called tanning [11].  Bursicon is a heterodimer neurohormone (α and β at a 
1:1 ratio) that regulates the sclerotization and melanization of the insect cuticle after 
ecdysis [54–59].  Bursicon is released during ecdysis and mediates the activity of  
insect tyrosine hydroxylase [60,61].  In crustaceans, little is known about the control 
of postmolt events, but the recent findings of a crustacean bursicon suggest that this 
hormone may have roles similar to insect bursicons [62–65].  Indeed, the release of 
bursicon is found in the hemolymph of Callinectes sapidus, the concentration of 
which peaks at the completion of ecdysis [62].   
Chung et al. [62] suggested that crustacean bursicon might participate in the 
shell-hardening process of crustaceans.  The hormone could play a role in hemocyte 
granulation underneath the hypodermis during ecdysis.  This information suggests 
that crustacean bursicon may regulate the sclerotization process.  More specifically, it 
may regulate the activity of hemocyte PPO and PPO cascade system, if the hemocytes 




Defining the role of crustacean PPO and bursicon in the cuticle hardening 
process, are essential for understanding the initial shell-hardening process in 
crustaceans.  This study tested the hypothesis that hemocyte PPO could be a 
component of the shell-hardening process of crustaceans, using the blue crab C. 
sapidus as a model.  It also investigated if crustacean bursicon is involved in the 
activity of hemocyte PPO during postmolt.  The results provide evidence that 
hemocyte PPO is involved in the shell-hardening process of crustaceans.  It was also 
found there are three main types of hemocytes that distribute in the hemolymph and 
contain PPO in a molt stage-dependent manner, suggesting particular roles for each 
hemocyte type during the molting cycle.  Bursicon may not directly mediate the 
activity of PPO in hemocytes, but the homodimer forms of this protein may be related 







Chapter 1: Background and significance of the research 
1.1. Molting and crustacean cuticle 
Crustacean somatic growth requires the shedding of the exoskeleton through a 
periodic molt process.  The molting cycle and molt are orchestrated by various 
hormones and neurohormones (ecdysone, molt-inhibiting hormone, crustacean 
hyperglycemic hormone, and crustacean cardioactive peptide hormone, etc.) which 
act in a concerted manner [4–7,9,62,66].  The molt cycle involves the synthesis and 
deposition of a new soft cuticle during the premolt, the shedding of the old 
exoskeleton (ecdysis), and hardening of the new cuticle at postmolt [1,2,18]. 
Four layers form the crustacean external cuticle (exoskeleton): the epicuticle, 
exocuticle, endocuticle, and membranous layer (Figure 1A).  Tanned lipoproteins and 
calcium carbonate constitute the epicuticle, the outer layer.  The exocuticle and 
endocuticle contain chitin-protein fibers and calcium carbonate, but unlike the 
exocuticle, the chitin-protein fibers are not tanned in the endocuticle.  Endocuticle is 
the thickest layer and is followed by the membranous layer.  The membranous layer 
is composed only of chitin (> 70%) and protein fibers without any mineral material.  
As the membranous layer is the last to be laid, completion of its secretion marks the 





Figure 1. At the intermolt stage the exoskeleton of crustacean is hard and 
formed by (A) a set of 4 different layers.  B) The layers are secreted by 
hypodermal cells at specific time through premolt and postmolt.  Epicuticle 
and exocuticle are secreted before ecdysis (pre-ecdysial layers).  Endocuticle 
and membranous layer are secreted during postmolt (post-ecdysial layers). 
During postmolt the shell-hardening process transforms the three outer layers 
in the hard exoskeleton.  The diagrams are based on Smith and Chang (2007).  





The molt cycle is largely divided into four stages: premolt, ecdysis, postmolt, 
and intermolt [1,2,68].  The hypodermis cells secrete the new cuticle (Fig. 1B) before 
and after ecdysis (premolt: D1 and D2 stages; postmolt: A and B stages).  At the 
beginning of early premolt, marked as “apolysis,” the hypodermis synthesizes 
proteolytic enzymes to re-absorb the component materials of the membranous layer, 
thus separating the hypodermis from the rest of the old hard cuticle.  Then, the outer 
cells of the hypodermis begin to secrete the new epicuticle.  Upon the completion of 
laying the new epicuticle, the exocuticle is then secreted [2,18].  In contrast to the epi- 
and exocuticle, the endocuticle and membranous layer are deposited by hypodermal 
cells after the ecdysis (Fig. 1B) [2,15,67]. 
The hardening process of the new cuticle is gradual and takes place over 
different time scales: the sclerotization of epicuticle and exocuticle occurs before and 
after ecdysis, respectively [2,18].  The calcification occurs in the top three outer 
layers, starting about two hours after ecdysis when the body expansion is completed 
(timing may change among the different species and size of animals) [2,15,18,69–72].  
The body expansion is the distension of the crustacean soft body into the maximal 
size by the isosmotic intake of water [2,15,67] using an active influx of ions into 
hemolymph via gills and gut [73].  Then the animals display the molt-related somatic 
growth. 
1.2. Shell-hardening process 
In crustaceans, the shell-hardening process involves both the initial 
sclerotization and subsequent calcification [2,13,15,69–72].  Sclerotization involves 




the organic matrix of cuticles.  These catalytic processes result in the cross-linking 
between proteins and chitin fibers [17,21], forming a stiff organic network.  The 
calcification process involves the deposition of calcium carbonate (CaCO3) and 
calcium phosphate [Ca3(PO4)2] within the organic network.  This mineralization 
process is dependent on the type of proteins integrated in the cuticle, the previous 
sclerotization, and chitin concentration [15,69,70,74–79].  
Cuticle sclerotization has well-been studied in insects [11,12,17,21,27,35], 
and it is recognized as the last hormonally regulated step of ecdysis [60,61].  In 
addition to the hormonal regulation of the cuticular tanning, laccase and tyrosinase 
enzymes, and dopa-decarboxylase (Ddc) play crucial roles in the “cross-linking” of 
proteins and chitin (Figure 2) [11,12,14,17,21].  In the first part of the phenol cascade, 
tyrosinase and/or tyrosine hydroxylase converts tyrosine into 3,4-
dihydroxyphenylalanine (DOPA).  Then, the enzyme Ddc decarboxylates DOPA into 
dopamine, which is the substrate for the synthesis of melanin, N-acetyldopamine 
(NADA) and N-β-alanyldopamine (NBAD).  NADA and NBAD can be 
enzymatically oxidized by tyrosinase and laccase [21] and becoming the precursors of 
ortho- and para-quinones.  Quinones initiate the last part of the cuticle sclerotization 
[17,21]. 
PO converted from the inactive zymogen (PPO) by prophenoloxidase-
activating enzyme (PPAE), seems to be the major component of the phenol cascade in 
the sclerotization of arthropods’ shells [17,44,80].  PPO also plays an important role 
in the innate immunity of insects and crustaceans [43,80,81].  It catalyzes the melanin 




pathogenic microorganisms thru the PPO cascade system  [23,43,80–83].  In the 
innate immunity of crustaceans, the phenol cascade occurs as in insects [43], but the 
involvement of this pathway in the shell-hardening process has not yet been well-
defined. 
 
1.3. The phenoloxidase enzymes 
Phenoloxidase is a common name for closely related copper containing 
oxidases.  The two main POs are tyrosinases and laccases.  However, hydrogen 
peroxidase (HPO) and tyrosine hydroxylase (TH) may also be included in the same 
group of POs due to its phenol activity.  It is likely that HPOs are marginal implicated 
in the cuticle sclerotization process, but THs appear to participate at the first step 
(Fig. 2) of insect cuticle tanning [12,14,17,20,21,48,50,51,84]. 
Tyrosinase enzymes are type III copper proteins in which the dioxygen-copper 
binding site belongs to the hemocyanin family [20,85,86].  Tyrosinases can both 
hydroxylate monophenols to ortho-diphenols (i.e. L-tyrosine to L-DOPA) and oxidize 
the ortho-diphenols to ortho-quinones (i.e..L-DOPA to dopamine) [21,87,88].  
However, it is reported that their hydroxylation capacity to monophenols is somewhat 
limited [89].  Tyrosinases act through a pathway that does not generate free radicals 
and cannot oxidize para-diphenols.  Their activity is inhibited by phenylthiourea and 
thiourea [21].  Moreover, the tyrosinases from hemocytes lack a signal peptide, 
indicating they are not secreted proteins [47,89].  These hemocyte tyrosinases are 
usually synthesized as zymogens (proenzymes) and known as PPOs, which need to be 




activate PPOs, the cleavage of its N-terminus takes place by the action of serine-like 
proteases, often called, in crustaceans and insects, PPAE [26,36]. 
 
Figure 2. Proposed diagram that illustrates a putative sclerotization process in 
arthropods (modified and based on insects; Andersen and Peter, 1996; 
Andersen, 2012, 2010; Sugumaran, 1998).  POs convert the phenol precursors 
in the corresponding quinones, which spontaneously react with the proteins and 
chitin fibers. This reaction produces as a result the cross-linking of the organic 
component of the cuticle, the sclerotization.  Tyrosinase (PPO) can hydroxylate 
tyrosine to DOPA and oxidize dopamine to NADA.  Independently, laccase 
can oxidize dopamine to NADA or NBAD.  In each step of the pathway where 
the catalyst is shown as PO*, the precise nature of the enzyme is undefined. 
PPAE = PPO-activating enzyme. 
 
Laccases, also called multi-copper oxidases (MCOs), are multi-copper 
containing enzymes.  Most of these enzymes contain a copper ion in a type I site and 




diphenols to the corresponding quinones using a free radical pathway, but they are 
unable to hydroxylate monophenols substrates [12,17,21,87].  They are usually 
associated with cuticles and protein matrixes, and are more thermostable than cuticle 
tyrosinases.  Their activities can be inhibited by azides or fluorides, but not by 
phenylthiourea [17,21,27].  The majority of laccases do not need proteolytic 
activation to perform their enzymatic activity.  Hence, they are not produced as 
zymogen [21]. 
THs are well-known enzymes which catalyze the hydroxylation of tyrosine 
into DOPA as precursor of dopamine.  Unlike tyrosinases and laccases, THs are iron-
containing mixed-function oxidases, and therefore require oxygen and the cofactor 
tetrahydrobiopterin to catalyze the substrate [90].  Although it usually shows a low 
enzyme activity [91], the phosphorylation at Ser40 of THs increases its activity [91].  
This post-translational modification mediates the TH enzyme activity [91].  
Furthermore, their enzyme activity is inhibited by iron-chelators and tyrosine 
analogues [52].  The arthropod forms of TH differ from the counter parts of 
vertebrates by requiring a more alkaline pH and higher affinity to the pterine cofactor 
[52].  All THs are neuro-expressed enzymes [52].  TH are clearly identified in insects 
and related to cuticle sclerotization [48,50,51].  However, in crustaceans, the studies 
of THs have been focused on their enzymatic synthesis of dopamine as a 
neurotransmitter and not their role as component of the cuticle shell-hardening 
process [53]. 
The functional phenol activity of HPOs suggests that they may involve in the 




seems to be so far speculative [17,21,92].  HPOs have a PO activity that depends on 
hydrogen peroxide and that it could be acting on ortho-diphenols and ortho-quinones 
[14,21,92]. 
 
1.4. Sources of PPO and PO activity 
In most arthropods, hemocytes are the main known source of PPO [38,93–95].  
There are three main types of hemocytes widely accepted in crustaceans, based on 
morphology and chemo-analyses: granulocytes, semigranulocytes, and hyaline cells 
[37,82,96–98].  The composition of both the hemocyte population  in the hemolymph 
and its PO activity vary during the molt cycle [95].  The hemocyte PPOs perform a 
fundamental role in the innate immunity as the final target enzyme in the PPO 
cascade system [80,99]. 
Nevertheless, it appears that the cellular source for PPO is controversial.  In a 
study on the shell-hardening process of Uca pugilator, the fiddler crab, Vacca and 
Fingerman (1983) stated that the hyaline hemocytes were the source of PPO during  
ecdysis.  Later, other authors described granulocytes (semi and granular) as the 
exclusive PPO hemocyte source.  Most of these studies, however, focus on the 
immune role of hemocytes at the intermolt stage rather than throughout molting cycle 
[82,97,98,100–105].  Hose et al. (1990) reported that the granulocytes contain PO 
activity whereas a small group of hyaline cells found in Panulirus interruptus and 
Loxorhynchus grandis also showed PO activity.  Therefore, it remains to be 





On the other hand, arthropod hemocyanin exhibits PO activity like 
tyrosinases, because they contain a hemocyanin domain carrying the dioxygen-copper 
binding site [19,20].  The enzymatic properties and immune role of hemocyanin have 
been observed by in vitro proteolytic activation [85,106,107].  In the Chelicerata 
group of arthropods (the horseshoe crabs) does not carry PPOs or POs [108].  Their 
hemocyanin is the protein with PO activity in their blood.  Thus, it has been 
suggested that hemocyanin may be involved in the cuticle sclerotization, possibly in a 
limited capacity [38,86]. 
Cryptocyanin is similar to hemocyanin in terms of protein sequence, size, and 
structure, but without binding oxygen or PO activities.  Cryptocyanin increases its 
concentration in the hemolymph during premolt to be the primary protein [84].  Its 
concentration drastically declines during ecdysis, while the localization of this protein 
is found beneath the new cuticle [109].  Therefore, the role of cryptocyanin has been 
suggested as a transporter of hormones, ions, catecholamines or PPO [84,109]. 
Recently, a novel crustacean PPO has been reported in kuruma prawn, 
Marsupenaeus japonicus [47].  This PPO, associated with melanization during 
immune response, is expressed in the hepatopancreas and not hemocytes.  This 
finding may indicate that crustacean melanization and cuticle sclerotization processes 
share some common features, which may be complex and require more than one 
PPO.  Additionally, the finding that hindgut of insects use PPO as the last line of 
immune defense to clear pathogenic bacteria before the secretion of feces [110], 





1.5. Hematopoiesis and hemocytes 
In coelomate animals, hemocytes are a fundamental component of the 
immunity system, which are usually found in the lumen of vascular cavities and 
coelom [111].  Frequently, a specialized tissue named as hematopoietic tissue (HPT) 
is the source of different hemocytes.  HPT contains the stem cells which divide and 
differentiate into mature hemocytes.  In most invertebrates, HPT is a mesenchymal, 
or gland-like structure, usually attached to the lining of either blood vessels or 
celomic cavities [111–113].  In decapod crustaceans, this tissue is described as a 
series of ovoid lobules which form a thin layer on the top part of the foregut [114–
116].  The lobules contain the hemocytes stem cells (HSC), frequently called 
hemocyte progenitors in invertebrates [102,111,116,117], which advance in the 
prohemocytes.  Later, prohemocytes will differentiate into mature hemocytes that will 
be released to the hemolymph [82,102,115,116,118]. 
The HPT of Pacifastacus leniusculus, a crayfish, has been well-studied and is 
used as a reference for all the decapod crustaceans.  Five different types of 
prohemocytes are found within the lobules of this model [116].  Usually, crustacean 
hemocytes are considered to divide in the hemolymph [39,119], and as a result, the 
crustacean HPT is the primary source for all the types of hemocyte during the 
crustacean lifespan. 
Hemocytes of all the arthropod groups have been investigated.  However, 
there is much controversy over the hemocyte cell types and terminology because of 
the classification criteria [117,120].  The major hemocyte types in invertebrates, 




hyaline cells, granulocytes, and eleocytes [111,120].  Prohemocytes are small, round 
cells with a low cytoplasm/nucleus ratio, and correspond to the majority of immature 
hemocyte cells in the HPT [111].  Hyaline cells also called plasmatocytes or glassy 
hemocytes.  They are differentiated cells either without or with few granular 
inclusions.  Hyaline cells are typically phagocytic cells (macrophage-like) 
[82,101,103,104,111,115,120–122]. 
Granulocytes contain a dense number of granules in the cytoplasm 
[82,101,103,104,111,115,120–122] which correspond to enzyme-filled lysosomes 
[111].  These cells are involved in metabolic and developmental functions, but their 
principal role is in the innate immunity system as a source of cytotoxic and opsonic 
proteins and enzymes [116,119,123–126].  Eleocytes (or oenocytoids) are large oval 
cells that lack normal organelles, but with oleo inclusion and crystalline microtubules 
which agglomerate in the cytoplasm. As a result, they are also called crystal cells and 
are mainly found in insects [111,120,122,127]. 
In decapod crustaceans, the morphological classification of three main types 
of hemocytes; granulocytes, semigranulocytes, and hyaline cells is accepted 
[37,82,96–98].  The differentiation of each of these hemocytes occurs in the HPT 
before being released into the hemolymph stream.  In crayfish, two lineages of cell-
differentiation take place to form the three main types of crustacean  hemocytes 
[102,115,116,123].  One of the lineages of prohemocytes produces the 
semigranulocytes and granulocytes, while hyaline cells have been shown to flow from 
an independent cell lineage [115,116,123].  The development and differentiation of 




cytokines (astakines) and transcription factors (GATA-like), which modulate the HSC 
in the HPT [102,115,116]. 
Crustacean hemocytes have shown different functions in immunity.  Cell 
cooperation and cell communication seem to be necessary to perform defensive 
reactions that allow detection, recognition and control of pathogens and parasites 
[39,40,80,81,89,128–134].  In the immunity system, while granulocytes are 
mentioned as the storage and  release source of the PPO system, they are also 
involved in cytotoxicity [39,40,133].  Semigranulocytes are involved in 
encapsulation, limited phagocytosis, storage and release of the PPO and cytotoxicity 
as well [39,40,133].  Hyaline cells have the function of phagocytosis [39,40,133].  In 
a typical fungal infection, crustacean glycan-binding proteins (βGBP) are activated in 
the plasma, which recognize and bind to the cell wall of the fungal intruder.  
Afterwards, semigranulocytes and granulocytes respond to the βGBP, releasing the 
PPO system in the place of the infection by degranulation.  The degranulation of 
these two types of hemocytes includes the secretion of opsonic and cell-adhesion 
factors (i.e. peroxinectin) [135].  The immune reaction is completed by hyaline cells, 
which respond to the opsonic factors performing the phagocytosis of the encapsulated 
pathogens [119,135] and dead cells. 
 
1.6. Hormonal control of the shell-hardening process 
In insects, the ecdysis and the cuticle sclerotization is a result of interactions 
among many hormones such as ecdysteroids, eclosion hormone, ecdysis triggering 




glycoprotein neurohormone bursicon (Burs) initiates the tanning pathways of the 
cuticle in the last step of ecdysis and postmolt [56,137,139].  This hormone is a 
heterodimer protein encoded, in insects, by the burs and pburs genes.  While burs 
encoded burs or alpha (α) subunit, pburs encoded the pburs or beta (β) subunit 
[56,60,140].  The mechanism of action of Burs is through its intracellular second 
messenger, cAMP [141]. 
Critical roles in the post-ecdysis events are mediated through regulation of the 
hydroxylation of tyrosine in the phenol cascade of melanin synthesis and cuticle 
sclerotization.  In Drosophila, flies with a mutated burs gene have shown imperfect 
tanning [60] as a consequence of inactivation of TH, one of the enzymes that catalyze 
tyrosine into DOPA (see section 1.3).  In the case of the fly, the phosphorylation of 
TH was disrupted, but this did not represent a deficiency in its gene expression.  The 
injection of cAMP, the second messenger of Burs, reversed this situation [61], 
suggesting that this hormone upregulates the activity of TH and not its transcription.  
Arakane et al [28] showed that laccase 2 is the key PO in the tanning process of 
Tribolium castaneum.  The enzyme laccase is essential for NAD and NBAD 
oxidation to synthesize the final quinones that sclerotize the new cuticle.  In T. 
castaneum, the injection of burs(α+β)-dsRNA into pharate pupae did not affect its 
cuticle tanning or survival after adult ecdysis; however, the capacity to expand the 
wing was disrupted.  This phenotype indicates that laccase activity may not be 
targeted by bursicon in this insect species [138].  Honegger et al [56] have suggested 




The hormonal mechanism that regulates the sclerotization in crustaceans is 
poorly understood.  Recently, the cDNA of Burs has been isolated from the thoracic 
ganglion complex (TGC) of several crustacean species [62,64,65] including Daphnia 
arenata, Carcinus maenas, Homarus gammarus, H. americanus, and C. sapidus.  
However, its specific role in crustacean development is still unclear (Wilcockson & 
Webster, 2008; Sharp et al., 2010; Chung et al., 2012).  In C. sapidus, the co-release 
of CCAP and Burs was measured in the hemolymph at the highest levels of 8x10-11M 
of concentration at the completion of ecdysis (Chung et al., 2012).  Even more, the 
presence of bursicon (hetero and homodimer) in pericardial organs (release site of 
Burs), as well as transcripts and proteins in TGC (expression site of Burs), remain 
constant throughout the molt cycle, suggesting that bursicon may have functions that 
are not associated molting.  Insect bursicon homodimers (homo-Burs) have shown a 
different function and receptor than the heterodimer bursicon, the active hormone 
[56,58,60].  While the heterodimer bursicon participates in cuticle tanning and wing 
expansion, the homo-Burs have been shown to promote the transcription of genes 
involved in innate immunity during ecdysis [142]. 
 
1.7. Cuticle proteins and cuticle mineralization 
The cuticle synthesis and the hardening process require protein-supplies that 
will largely be the target of the sclerotizing components.  The principal hemolymph 
proteins (PPO, hemocyanin and cryptocyanin) have been mentioned above (section 
1.4).  The physiological roles of these proteins during molting likely involve 




possible incorporation to the new cuticle, and supplying oxygen to tissues and to 
reactive components that will be sclerotized in the formed cuticle [84]. 
Furthermore, a direct relationship between the amounts of cuticle proteins and 
the degree of calcification has been suggested.  Since the deposition of carbonate 
crystals seems to depend on the soluble organic matrix that is cross-linked in the 
cuticle [78,143], the insoluble components such as chitin and chitosan inhibit the 
carbonate crystallization when the matrix contains little or no proteins [143].  
Moreover, Coblentz et al. (1998) have proposed a working model that suggests that 
the changes in the cuticle protein composition are responsible for the different levels 
or/and timing of mineralization after ecdysis.  This protein mediation may be 
responsible for the differences in calcification among the different parts of a 
crustacean body (external and internal cuticles).  It is evident that there is a 
differential biomineralization between the dorsal carapace and chelipeds (heavily 
calcified) versus the suture line zone (thinly calcified) [76].  Therefore, the cuticle of 
the joints, gills, and walls of the brachial chamber can remain flexible and 
uncalcified. 
Observations on the arthrodial membranes, which remain flexible and 
uncalcified after ecdysis, provide some supporting evidence.  Comparing the 
arthrodial membranes with the hard cuticle of the carapace, no differences in their 
layers or lamellae structure is found.  Both are also secreted at the same time during 
the molt cycle.  However, their organic matrix composition is different (Hepburn and 
Chandler, 1976 in Shafer et al., 2006; Williams et al., 2003).  On the other hand, 




mobility (early postecdysial period), and glycosidase activity are found in the cuticle 
in different areas and molt stages [74,77].  Several biochemical changes by the 
recruitment of proteins before ecdysis together with conformational changes of the 
proteins after ecdysis, seem to mediate the sclerotization and mineralization.  The 
regulatory process of these changes which could be under hormonal control, has not 
been studied yet. 
 
1.8. Significance of the research 
The shell-hardening process in crustaceans begins with the cuticle 
sclerotization.  The information available in insects suggests that several POs act in 
concert for tanning the new cuticle.  To date, only PPOs have been reported from the 
hemocyte of crustaceans, except a recently report that describes a PPO expressed in 
the hepatopancreas, and not in hemocytes [47].  It is not well-defined in crustaceans 
which type of hemocyte expresses PPO; if the cellular source of PPO may vary 
during the molt cycle, specifically at ecdysis and postmolt; and if this PPO is directly 
involved in the initial shell-hardening process.  
Additionally, bursicon in most insects is the hormone that address the cuticle 
tanning and controls the activation of TH.  In crustaceans it is known the hormone is 
present throughout the molt cycle.  While its concentration increases in the 
hemolymph during ecdysis its role in cuticle sclerotization is still undetermined. 
Previous findings suggest that crustaceans may have an intricate shell-
hardening system, which may involve components from the immunity and endocrine 




of crustaceans may provide information on arthropod hard exoskeleton formation and 
evolution.  It is possible that this knowledge may also contribute to crustacean fishery 
and aquaculture industry, where the period of softness after the ecdysis affects 
survival and growth.  Soft shell crab production is of particular interest due to the 
seasonality and availability of peelers.  More importantly, the production of soft shell 
crabs also depends on a short duration of the shell-softness at postmolt.  Moreover, a 
better understanding of the crustacean shell-hardening process may contribute to 
generate biotechnological solutions on invasive and parasite crustacean species.  An 
example is the sea louse (Calligus spp), a copepod group of parasite crustaceans that 
cost millions of dollar to the worldwide salmon industry. 
 
1.9. Objective of the study 
To understand the molecular mechanisms that regulate the initial shell-
hardening process of the blue crab C. sapidus, the involvements of hemocyte PPO 
and the hormone bursicon are investigated.  This study proposes the hypothesis that 
the shell-hardening process of crustaceans may rely on the presence of hemocyte PPO 
that may be differential expressed during the molt cycle.  And this process may be 
regulated by bursicon. 
To test the hypothesis, three specific objectives are carried out: 
 
1. Objective 1: Identify a hemocyte PPO from the blue crab, C. sapidus and 




The objective 1 includes the molecular isolation and identification of PPO cDNA 
sequence (CasPPO-hemo) cloned from hemocytes of C. sapidus.  The CasPPO-
hemo expression during the molt cycle and the characterization of hemocyte PO 
activity is included.  It is also incorporated the quantification of total hemocyte 
number and their derived PO activity during the molting cycle. 
 
2. Objective 2: Examine the inherent changes in hemocyte PO activity during the 
molt cycle and its role in the initial shell-hardening process of the blue crab C. 
sapidus. 
The objective 2 includes the differentiation of main hemocyte types in the 
hemolymph of the blue crab during the molt cycle.  It also states the 
identification of the specific hemocyte types that are the source of CasPPO-hemo 
during the molt cycle, using immunostaining and flow-cytometry.  Moreover, the 
role of PPO and hemocytes during the shell-hardening process is determined 
using the multiple injections of specific CasPPO-hemo-dsRNA.  Specifically, the 
effect of dsRNA on the shell-hardness is measured. 
 
3. Objective 3: Investigate if bursicon regulate the activity of PPO during the shell-
hardening process of the blue crab C. sapidus. 
The objective 3 includes the expression analysis of CasPPO-hemo in hemocytes 
and its PO activity after the post transcriptional knockdown of Callinectes 
bursicon using multiple injection of CasBurs-dsRNA, together with CasBurs-α or 




also examined.  More specifically, the levels of CasPPO-hemo hemocyte 
expression and its enzyme activity are determined together with total hemocytes 
number and differential hemocyte population.  The levels of CasPPAE 





Chapter 2: Cloning of prophenoloxidase from hemocytes of the 
blue crab, Callinectes sapidus and its expression and enzyme 
activity during the molt cycle  
 
2.1. Abstract 
The arthropods’ cuticle undergoes dramatic morphological and biochemical 
changes from being soft to hardness through each molting process.  Prophenoloxidase 
(PPO) known as a key enzyme in the arthropod innate immune system involved in the 
melanization reaction, has been related to the initial shell-hardening process, 
specifically in the sclerotization of the protein matrix in the new cuticle.  Since 
hemocytes have been reported as the main PPO source in arthropods, the transport of 
hemocyte PPO into the newly laid, soft cuticle has been proposed for shell-hardening 
occurring during and immediately after ecdysis.  In order to define the role of 
hemocyte PPO in the shell-hardening of crustaceans, the full-length cDNA sequence 
(2,806 nt) of hemocytes PPO of the blue crab Callinectes sapidus (CasPPO-hemo) is 
isolated using degenerate PCR and 5’ - 3’ RACE.  CasPPO-hemo encodes a putative 
PPO (672 aa) showing three hemocyanin domains: N, M, and C in order and two 
copper binding sites (CuA & CuB).  The sequence analysis identifies the putative 
CasPPO-hemo as zymogen which requires the cleavage at the N-terminus for its 
activation.  Hemocyte extract (CasHLS) contains the PO, the activity of which 
depends on the in vitro activation of trypsin.  The expression levels of CasPPO-hemo 
are kept constant during the molt cycle.  The increase in the number of hemocytes at 
early premolt correlates with the elevated PO activity, while at late premolt, the 




importance of the changes in the levels of CasHLS-PO activity during molt cycle is 
discussed in relation to the cuticle hardening process. 
 
2.2. Introduction 
As one of most important immune systems in invertebrates, prophenoloxidase 
(PPO) cascade plays a central role in melanization in response to the invasion of 
pathogens and wound healings  [17,38,44,80].  PPO is produced as an inactive form 
of zymogen that requires a serine protease, prophenoloxidase activating enzyme 
(PPAE) for its activation.  Hemocytes are recognized as the principal source of PPO 
in arthropods including crustaceans [23,38,80,81,83,94].  
Together with the changes in the total number of hemocytes, the levels of 
PPO expression and enzyme phenoloxidase (PO) activity in hemocytes are often 
associated with physiological conditions of the crustaceans including stress by 
environmental factors, harvest, microbial and fungal infections [83,145–151].  
Specifically, the molt cycle appears to influence not only the number but also the type 
of hemocytes together with PO activity, especially with respect to a molt stage 
dependent susceptibility to disease [98,149,152].  In these species, animals at post-
molt stage had hemocyte numbers lower than those at intermolt, which also 
corresponded to levels of PO activity relevant to each of these molt stages.  
Interestingly, the PO activity present in hemocytes may participate in the 
sclerotization of the initial shell-hardening process of the new cuticle of crustaceans 
[37,38].  This is due to the finding that the hemocyte aggregation occurs underneath 




bursicon, an arthropod tanning hormone, has been recently found to induce the 
recruitment and granulation of hemocytes beneath the hypodermis of the blue crab, 
Callinectes sapidus at ecdysis [62].  
PO activities have also been measured  in the cuticle of insects and 
crustaceans [14,153–156].  The cuticles undergo dramatic changes during molt cycle 
from softness during and after ecdysis to hardness most of the molt cycle and provide 
the first defensive barrier against invasive microorganisms [23,157].  More 
specifically, two insect studies show that PPOs present in the cuticle have been 
transported from hemolymph [25,30], while a laccase of Tribolium castaneum, a PO 
regulating the tanning of the new cuticle after ecdysis is not originated from insect 
hemocytes [31].  These reports suggest that POs either in hemocytes or cuticles may 
play a critical role in initial shell-hardening process of arthropods, the process of 
which resembles melanization reaction.  We hypothesized that if a PO is involved in 
shell-hardening of crustaceans, hemocytes may be one of the sources.  
To better understand the molecular mechanism(s) underlying the initial shell-
hardening process after ecdysis of C. sapidus, we first isolated the cDNA sequence of 
PPO from hemocytes and characterized the PO activity.  Herein, this paper reports 
the isolation of the full-length cDNA sequence of PPO from hemocytes of C. sapidus 
(CasPPO-hemo) using PCR with degenerate primers and 5’ - 3’ RACE and the levels 
of its expression during the molt cycle using a qPCR assay and of PO activity.  With 
the changes in the levels of CasPPO-hemo expression, the PO activity in hemocytes 
and their numbers during the molt cycle, a functional role of PPO present in 




2.3. Materials and methods 
2.3.1. Animals 
Juvenile blue crabs, C. sapidus (15 – 30 mm carapace width, CW), were 
received from the blue crab hatchery [Aquaculture Research Center, the Institute of 
Marine and Environmental Technology (IMET), Baltimore, MD].  The animals were 
maintained in tanks with individual cages in aerated and recirculated artificial 
seawater at 22ºC and 20 ppt as described [62,158,159].  They were fed daily with a 
piece of squid and monitored their growth.  The crabs with 75-85 mm CW were molt-
staged as described [160]. 
2.3.2. Molecular cloning 
The total RNA was isolated from hemocytes obtained from animals at various 
molt stages as describe Chung et al. and Chung & Zmora [158,159,161], using a 
QIAzol Lysis Reagent (Qiagen) following the manufacturer’s protocol.  The total 
RNA concentration and purity was estimated using a NanoDrop spectrophotometer 
(FisherSci). All RNA samples treated with DNase I (Fermentas) were subjected to 
syntheses of cDNAs using MMLV transcriptase (Fermentas) or 5’- 3’ RACE cDNAs 
using a SMART™ cDNA synthesis kit (BD Biosciences). 
Degenerate primers (Table 1) for C. sapidus PPO from hemocytes (CasPPO-
hemo) were designed with the conserved regions based on the multiple sequence 
alignment of known crustacean PPOs listed in GenBank.  A two-step PCR 
amplification was employed for degenerate PCR and 5’- 3’ RACE as described 




CasPPOd3F1 primer and universal primer(UPM, BD Biosciences) at the following 
PCR conditions: 94ºC, 2.5 min; 94ºC, 30 sec, annealing temperature decreasing 
1ºC/cycle starting at 47ºC and ending at 40ºC, 30 sec (8 cycles), extension at 72ºC for 
2 min; 27 cycles at 94ºC, 30 sec, 48ºC, 30 sec, 2 min extension, and final extension at 
72ºC for 7 min.  The first PCR product was used as the template for the nested PCR 
after being diluted 20 fold in sterilized water with a combination of CasPPOd3F2 and 
CasPPOd5R2 (Table 1) at PCR conditions: 94ºC, 2.5 min; 40 cycles at 94ºC, 30 sec, 
57ºC, 30 sec, 72ºC, 1 min; final extension at 72ºC for 7 min.  The nested product was 
electrophoresed on a 1.5% agarose gel.  The band at the expected size of ~1,100 bp 
was excised and used for cloning and sequencing as described [159].  Based on this 
initial sequence of CasPPO-hemo, gene specific primers (Table 1) for the cloning of 






Table 1. List of primer sequences that were used for the full-length cloning of 
CasPPO-hemo and qPCR assays 




















QF and QR primers used for qPCR assays 
 “d” indicates the degenerate primers. 
 
For 5’ and 3’ RACE, a similar two-step PCR method was employed as above. 
Briefly, for 5’ RACE, 5’RACE cDNA (50 ng total RNA equiv.) was amplified with 
CasPPO5R1 and UPM at the following PCR conditions: first denaturation 94ºC for 
2.5 min; 94ºC, 30 sec, annealing temperature decreasing 1ºC/cycle starting at 57ºC 
and ending at 49ºC, 30 sec (8 cycles), extension at 72ºC for 2 min; 27 cycles at 94ºC, 
30 sec, 58ºC, 30 sec, 2 min extension, and final extension at 72ºC for 7 min.  This 
PCR product diluted 20 fold with sterilized water served as the template for the 
nested PCR with CasPPO5R2 primer and nested universal primer (NUP, BD 
Biosciences).  The nested PCR products were treated similarly as above for cloning 




cDNA and specific primers for the touch-down PCR with CasPPO3F1 and UPM and 
for the nested PCR with CasPPO3F2 primer and NUP (Table 1). 
The ORF sequence of CasPPO-hemo was confirmed with the amplification of 
cDNAs of three different crabs using a High Fidelity Tag polymerase (Bioline) and 
CasPPO3F4 and CasPPO5R4 (Table 1).  The phylogenetic analysis was carried out 
with the putative amino acid sequence of 19 number of crustacean PPOs including 
CasPPO-hemo (MEGA 5.05) [165]. 
2.3.3. Expression analysis 
The expression levels of CasPPO-hemo at different molt stages were 
estimated using a qPCR assay with Fast SYBR Green Master Mix (Applied 
Biosystems) on a 7500 Fast Real-Time PCR System (Applied Biosystems).  The 
standards of CasPPO-hemo were prepared similarly as described in Chung et al. 
[164].  The primers for the qPCR assay were selected in the region specific to 
CasPPO-hemo that is located between the hemocyanin domain M and C.  The data 
were normalized with the levels of arginine kinase (CasAK) expression in the same 
sample cDNAs [166].  The expression levels are presented as mean ± SE copies/µg 
total hemocyte RNA.  
The spatial expression of CasPPO-hemo was examined using an end point 
PCR assay with 10 different tissue cDNAs prepared from an animal at intermolt stage 




2.3.4. Sequence analysis 
The CasPPO-hemo cDNA sequence was analyzed using an ORF finder 
(www.ncbi.nlm.nih.gov/gorf/gorf.html) and RegRNA (regrna.mbc.nctu.edu.tw) 
[167].  The signal peptide was examined using Signal P 4.1 Server 
(http://www.cbs.dtu.dk/services/SignalP/).  The prediction of the potential N-
glycosylation and phosphorylation sites was performed with NetNGlyc 1.0 Server 
(http://www.cbs.dtu.dk/services/NetNGlyc) and NetPhos 2. 0 Server 
(http://www.cbs.dtu.dk/services/NetPhos), respectively.  The copper binding regions 
were located using SIB-MyHit motif scan (http://myhits.isb-sib.ch/cgi-
bin/motif_scan) and the identification of motif sequences was analyzed using NCBI 
Blast (http://blast.ncbi.nlm.nih.gov).  Potential kinase specific phosphorylation was 
predicted using Net- PhosK 1.0 Server (www.cbs.dtu.dk/services/NetPhosK/).  The 
identification of motif sequences and the sequence homology were done using the 
BLAST network server (http://blast.ncbi.nlm.nih.gov).  A phylogenetic tree using the 
deduced amino acid sequences of CasPPO-hemo including 19 PPOs obtained from 
crustacean species (Daphnia magna was considered as out-group) and seven insects 
was constructed using the Maximum Likelihood method by MEGA 5.05 [165] 
2.3.5. Total hemocyte counting (THC). 
The THC was estimated using a modified procedure as described in Chung et 
al. [56]. In brief, hemolymph samples (150 μl) were withdrawn directly into a fixative 
solution (paraformaldehyde 4% in 10mM cacodylate buffer, pH. 7.1) in a ratio of 1:1.  
The fixed hemolymph samples were then centrifuged at 800 g for 10 min at 4ºC.  The 




hemocytometer (Reichert Bright-Line) for counting under a compound light 
microscope.  Each sample was counted twice and the data were presented as number 
of hemocytes/ml hemolymph (n=4-12). 
2.3.6. Hemocyte Lysate Supernatant (HLS) 
The hemolymph (500 μl) from crabs at various molt stages were collected 
directly into a syringe containing a crab anticoagulant solution (450mM NaCl, 10mM 
KCl, 100mM  Glucose, 10mM NaHCO3, 10mM EDTA, 10mM HEPES, pH 7.3) at a 
ratio 1:1 (v:v).  The samples were kept on ice and centrifuged at 800g for 10 min at 
4ºC for hemocyte separation.  Each of these animals was used only once for just a 
single hemolymph collection.  The hemocytes were washed twice with 200 µl of 
sodium cacodylate (10 mM) by centrifugation as above.  The hemocytes were 
sonicated in 25 μl of working buffer (10 mM sodium cacodylate, 5 mM calcium 
chloride, pH 7.1) and then centrifuged at 15,000 g for 20 min at 4ºC.  The protein 
concentration of the supernatant as HLS was estimated using a Pierce 660 nm kit. 
2.3.7. Characterization of Callinectes-HLS (CasHLS) PO activity  
The CasHLS-PO activity was determined by measuring the formation of 
dopachrome from L- 3,4 dihydrophenylalanine (L-dopa) using a modified assay as 
described [46,168,169]. Briefly, HLS samples (45 μg HLS in 50 μl working buffer) 
were preincubated with 50 μl of trypsin (1 mg/ml working buffer) for 15 min at 37ºC. 
Subsequently, 100 μl L-dopa (3 mg/ml working buffer) were added and further 




with 150 μl of working buffer, were placed into a 96-well plate in triplicate (100 
μl/well), and the absorbance was measured at 490 nm. 
Substrate specificity of CasHLS was determined by evaluating the PO activity 
with four different phenol substrates at 3 mg/ml concentration: L-dopa, dopamine, 
catechol and L-tyrosine.  The PO activity was measured at 490 nm, except for 
catechol at 410 nm.  The proteolytic conversion of PPO into PO by trypsin was 
determined by subtracting the OD value obtained with cacodylate buffer alone.  
Ca2+ dependent PO activity was evaluated by adding CaCl2 to 10mM sodium 
cacodylate solution at the final concentrations of 0, 5, 10, and 20mM, while EDTA 
was added at 20mM final concentration.  L-dopa was used as a substrate, unless 
described otherwise. 
To further define the property of PO activity, sodium azide and thiourea 
known as PO inhibitors, were added into the substrate solution at 10mM final 
concentration.  
The PO activity was calculated as OD490 nm/mg HLS and presented as mean ± 
SE (n = 5-15, molt cycle analysis). 
2.3.8. Statistical analysis. 
For each experimental analysis the parametric assumption of normality 
(Kolmogorov-Smirnov test) and homogeneity of variances (Cochran C test) were 
evaluated on the data.  When the ANOVA test indicated significant differences at P < 
0.05, a post-hoc Tukey test was adopted to distinguish the source of variation.  The 
data that did not meet the parametric analysis, were analyzed with the non-parametric 




difference (Statistica 7.0, Stat Soft., Inc).  The data are presented as mean ± SE and 










Figure 3. The full-length cDNA sequence of CasPPO-hemo (GenBank 
JX047321) and its deduced amino acid sequence. The start codon of the ORF 
(atg) and the stop codon (*) are made in bold. The putative copper binding 
regions are identified by arrows in the H188, H190, H212 (CuA) and H347, H351, 
H387 (CuB). The predicted putative phosphorylation and glycosylation sites are 
shown in □ and ♦, respectively. The putative cleavage sites of PPO converting 
to PO are marked with ‘+’. The thiol-ester like motif (GCGWPQHM) is 
underlined within the ORF sequence. The regulatory elements in the 5’ UTR 







Figure 4. A) A schematic representation of the deduced sequence of CasPPO 
containing the three conserved hemocyanin N, M and C domains identified 
using the conserved domain search (http://blast.ncbi.nlm.nih.gov). The 
numbers below each domain indicate the location in the protein sequence. B) A 
phylogram generated with 19 PPOs of crustaceans and 7 insect species using 
the Maximum Likelihood method with 100 bootstrap replicates C. sapidus 
PPO (CasPPO-hemo) is marked in square. The scale bar represents fixed 





2.4.1. Cloning and sequence analysis of CasPPO-hemo 
The full-length cDNA of CasPPO-hemo (2,806 nucleotides, GenBank 
accession JX047321) consists of a 5’ UTR of 87 nt, a coding region (ORF) of 2,019 
nt, and a 3’ UTR of 700 nt (Fig. 3).  The open reading frame encodes a putative 672 
amino acid sequence of CasPPO-hemo (ORF finder, 
http://www.ncbi.nlm.nih.gov/projects/gorf/).  The 5’ UTR contains two terminal 
oligopyrimidine tract (TOP) regulatory RNA motifs (http://regrna.mbc.nctu.edu.tw).  
Two GAIT elements (Gamma interferon activated inhibitor of Ceruloplasmin mRNA 
translation) are found in the 3’ UTR (http://regrna.mbc.nctu.edu.tw). 
No signal peptide was predicted in CasPPO-hemo 
(http://www.cbs.dtu.dk/services/SignalP/) in which putative copper binding regions 
are identified in the His-188, His-190, His-212 (CuA) and His-347, His-351, His-387 
(CuB) (http://myhits.isb-sib.ch/cgi-bin/motif_scan).  A total of 22 putative 
phosphorylation sites were predicted (http://www.cbs.dtu.dk/services/NetPhos/) 
including 15 at S (S39, 81, 122, 138, 147, 198, 225, 235, 260, 410, 412, 435, 474, 532, 606), six at T (T20, 136, 
148, 482, 514, 647), and one  at Y389. Sixty four putative glycosylation sites were predicted: 
26 at S (S3, 39, 51, 59, 106, 147, 163, 164, 235, 252, 254, 260, 334, 355, 357, 410, 412, 413, 435, 468, 474, 476, 527, 528, 
612, 648), 21 at T (T20, 34, 56, 83, 135, 136, 148, 156, 257, 315, 376, 436, 482, 529, 534, 540, 601, 638, 651, 662, 664, 
671) and 17 at N (N64, 97, 183, 264, 290, 306, 307, 339, 362, 428, 461, 535, 537, 641, 655, 667). 
The Motif Scan web site MyHits (http://myhits.isb-sib.ch/cgi-bin/motif_scan) 
predicted one putative cAMP and cGMP-dependent protein kinase phosphorylation 




84; 122-125; 138-141; 147-150; 260-263; 283-286; 405-408; 412-415; 435-438; 540-
543), 6 protein kinase C phosphorylation sites (position 20-22; 435-437; 468-470; 
482-484; 514-516; 540-542), and one tyrosine kinase phosphorylation site (position 
203-210). 
Three conserved domains are found in the putative amino acid sequence of 
CasPPO-hemo (Fig. 4A): truncated hemocyanin N and the full hemocyanin M, and C 
domains (http://blast.ncbi.nlm.nih.gov).  A thiol-ester complement motif 
(GCGWPQHM, underlined in Fig. 1A) was also detected at the C-terminus of the 
protein sequence.  The putative cleavage sites for converting PPO to PO are found at 
R35-V36, R50-S51 and R94-F95 in the N-terminus of the putative CasPPO-hemo 
(http://web.expasy.org/cgi-bin/peptide_cutter/peptidecutter.pl).  
The CasPPO shows 70-87% sequence identity to other crustacean PPOs 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi).  A phylogenetic tree that was generated with 
19 putative PPOs of other crustacean species including Daphnia magna PPO (Fig. 
4B) contains three groups: 1) Portunidae and Cancridae including C. sapidus, 2) 
Penaeidae and Astacidae, and 3) Palaemonidae group (Macrobrachium sp.).  
CasPPO-hemo is most closely related to the PPOs found in species belonging to the 
family Portunidae: Portunus trituberculatus and Scylla serrata, compared to those 
belonging to the family Cancridae: Cancer pagurus and Metacarcinus magister. 
2.4.2. Tissue distribution of the CasPPO-hemo 
The expression of CasPPO-hemo is exclusive in hemocytes, while nine other 








Figure 5. Expression of CasPPO-hemo in the tissues obtained from a juvenile 
crab at intermolt stage. Each cDNA sample (equivalent of 12.5 ng total RNA) 
was amplified for the entire ORF (2,019 nt) using an end-point PCR assay with 
Myfi High-Fidelity taq (Bioline) at annealing at 58ºC; extension at 72ºC for 1 
min; 35 cycles). CasAK as a reference gene was amplified with the same 
sample cDNAs. ES = eyestalk; TGC = thoracic ganglia complex; BR = brain; 
HT = heart; G= gill; ATG = antennal gland; WM = white muscle (located at 
the base of the fifth walking leg); YO = Y-organs; HE = hemocytes; HYP = 
hypodermis. 
 
2.4.3. The levels of CasPPO-hemo expression in hemocytes during molt cycle 
The levels of CasPPO-hemo expression remain constant in all molt stages 
tested (ranging 1.8 x 105 copies/µg total RNA to 6.0 x 105 copies/µg total RNA), 
except in the ecdysis (Fig. 6A).  The expression levels of CasPPO-hemo at ecdysis 
show a large variation from 5.9 x 104 to 6.3 x 106 copies/µg total RNA.  The levels of 
arginine kinase (CasAK) measured as a reference gene in the same sample cDNAs, 
are constant throughout the molt cycle (Fig. 6B), except at premolt stage when the 






Figure 6. Expression levels of CasPPO-hemo (A) and CasAK (B) in hemocytes 
during the molt cycle. No statistical differences (Kruskal-Wallis ANOVA) are 
found in CasPPO-hemo or CasAK. The data are shown as mean ± SE 




2.4.4. Changes in CasHLS-PO activity and the number of circulating hemocytes 
during the molt cycle 
The number of total hemocytes and PO activity of hemocytes vary during the 
molt cycle (Fig.7).  The number of hemocytes at intermolt stage is 6.1 ± 0.8 x106 
cells/ml hemolymph, which is gradually increased to the highest levels of 12.1 ± 3.0 
x106 cells/ml hemolymph at late premolt.  The numbers are then reduced to the 
lowest density at ecdysis (4.8 ± 0.7 x106 cells/ml hemolymph), but at post molt stage 
(9.5 ± 1.9 x106 cells/ml hemolymph), they are gradually elevated to the similar levels 
of those at the premolt stage.  During the molt cycle, the levels of the CasHLS-PO 
activity change ~ three and a half folds with the highest at early premolt stage (2.9 ± 
0.4 OD/THC protein/ml of hemolymph) and the lowest at ecdysis (0.8 ± 0.3 OD/THC 
protein/ml of hemolymph).  These levels correspond to those of hemocyte numbers, 
except at late premolt. 
2.4.5. Substrate specificity of CasHLS 
CasHLS-PO activity requires the presence of trypsin in the reaction, showing 
a significant threefold increase in PO activity with diphenols (L-dopa, dopamine and 
catechol) as substrates.  CasHLS also contains a small amount of PO activity that is 
not dependent on the addition of trypsin. 
CasHLS-PO shows its substrate specificity in order of L-dopa, dopamine, 
catechol and L-tyrosine.  The greatest PO activity is noted with L-dopa (3.6 ± 0.7 
OD/mg HLS) followed by dopamine (1.2 ± 0.3 OD/mg HLS) and catechol (1.1 ± 0.2 
OD/mg HLS).  L-tyrosine yielded the lowest activity (P < 0.05) in about 0.1 OD/mg 






Figure 7. A) Changes in the number of hemocytes in the hemolymph (dashed 
line) and CasHLS-PO activity during the molt cycle (solid line). Different 
letters indicate significant differences at P < 0.05. The data are shown as mean 
± SE (the number of hemocytes/ml hemolymph, n=4-12) for THC and (OD/mg 
HLS, n=5-15) for PO activity. 
 
2.4.6. The effect of Ca2+ on CasHLS-PO activity 
The addition of EDTA, a divalent chelator, at 20mM final concentration 
significantly reduces PO activity present in CasHLS (Fig. 8B).  No additional Ca2+ to 
CasHLS yields the PO activity of 1.8 ± 0.7 OD/mg HLS that is ~ threefold higher 
than those with the addition of EDTA (0.5 ± 0.1 OD/mg HLS).  Additional Ca2+ at the 






Figure 8. Enzyme properties of PO activity located in CasHLS prepared from the 
crabs at intermolt. A) Substrate specificity: Open bars represent the activity 
without trypsin; closed bars, with trypsin (n=6). B) Ca2+ dependent PO activity 
(n=6). C) Inhibitors of PO activity (n=3). The data are shown as the mean ± SE 




2.4.7. Inhibitors of CasHLS-PO activity 
Thiourea and sodium azide known as the inhibitor of tyrosinase and laccase, 
respectively, were tested to determine if they suppressed the CasHLS-PO activity.  As 
shown in Fig. 8C, thiourea suppresses the CasHLS-PO activity by 50% (1.7 ± 0.2 
OD/mg HLS), compared to controls (P = 0.02), which shows an activity of 3.6 ± 0.3 
OD/mg HLS. Sodium azide, on the other hand, decreases CasHLS-PO activity, 
compared to controls, but no statistical difference is noted. 
 
2.5. Discussion 
This manuscript describes the isolation of the full-length cDNA sequence of 
CasPPO-hemo (2,806 nt) and the levels of its expression and PO activity during the 
molt cycle.  The properties of CasHLS-PO activity are further defined in terms of 
substrate specificity and a specific inhibitor.  Our results suggest that CaHLS-PO 
activity is likely to be a tyrosinase.  
Crustacean PPOs as the members of crustacean hemocyanin superfamily 
[20,38,85,170] consist of three putative structural hemocyanin domains: truncated N 
domain and two complete full M and C domains, and the signatures of PPOs with 
highly conserved two copper binding motifs.  The CasPPO ORF (2,019 bp) encoding 
a 672 putative aa sequence also display the two copper binding motifs and three 
putative hemocyanin domains, as those reported in P. trituberculatus, S. serrata, and 
L. vannamei [171–173].  With > 70% sequence identity among crustacean PPOs, 
CasPPO is related most closely to those found in other Portunidae crab species: S. 




It is widely known that the activation of zymogen PPO to PO depends on a 
trypsin-like proteinase known as PPAE.  Three putative sites cleaved by PPAE were 
predicted in CasPPO-hemo: R35-V36, R50-S51 and R94-F95.  In insects, a conserved R-F 
residue, usually located within the first 50 aa residues is known as the cleavage site 
for PPO activation [89]. Similarly, a PPAE cleaves crustacean PPOs at R-X residues 
(X= S in P. trituberculatus [173] and Eriocheir sinensis [45], L in L. vannamei [94] 
and V in S. serrata [172].  Hence, it is likely that the cleavage site of CasPPO may be 
either at R35-V36 or R50-S51. 
Twenty- two phosphorylation sites were predicted in CasPPO-hemo similar to 
Armigeres subalbatus [174]. CasPPO-hemo contains 64 putative glycosylation sites: 
47 O-glycosylation and 17 N-glycosylation. Particularly, the number of putative N-
glycosylation sites predicted in CasPPO is much greater than 4-7 putative sites found 
in other PPOs including Pascifastacus leniusculus [44], P. trituberculatus [173], A. 
subalbatus [174], S. serrata [172], L. vannamei [171], Cortesia glomerata [175] and 
Macrobrachium rosenbergii [176]. 
The distribution of PPO expression varies in crustacean and insect tissues.  In 
crustaceans like L. vannamei, E. sinensis, P. trituberculatus and Marsupenaeus 
japonicus,  tissues such as hemocyte, hepatopancreas, the stomach epithelium, 
midgut, and nerve cord cells have  PPO [45,47,94,173].  Insects (A. subalbatus, 
Anopheles stephensi, Ostrinia furnacalis, Pimpla hypochondriaca, Apis mellifera)  
also have  PPO in multiple tissues including hemocytes, serum, venom-producing 
cells, integument, epidermis, fat body and midgut [174,177–180].  In this study, PPO 




that hemocytes are likely the main source of PPO, as in other crustaceans (L. 
vannamei, S. serrata, and Penaeus monodon) [93,171,172].  However, since we 
examined only 10 tissues, it is likely that blue crabs may also have PPO expression in 
other tissues that have PPO in other crustacean species.  
Both insect and crustacean PPOs show stronger PO activity with diphenols as 
substrates than monophenols [25,35,181].  As expected, the CasHLS-PO activity 
prefers to diphenols: L-dopa, dopamine and catechol to monophenol: L-tyrosine. The 
highest PO activity is measured with L-dopa, together to dopamine.  Hence, the most 
crustacean PO activity has been evaluated with L-dopa as a substrate 
[45,46,149,151,182,183].  The CasHLS-PO activity is dependent on Ca2+, as the 
presence of EDTA (20mM) significantly reduces its activity.  This result  agrees with 
the POs found in other crustaceans which are known as Ca2+ dependent enzymes 
[46,168,169].  However, the required concentration of Ca2+ for PO activity seems to 
be negligible in C. sapidus, as the activity measured without additional Ca2+ is still 
significantly higher than those measured with EDTA. It is known that Ca2+activates 
PPAE for transformation into PO [169,184,185] and is required for trypsin reaction 
[186].  Thus, we suggest that Ca2+ in the reaction medium acts on trypsin activity but 
not on CasHLS-PO activity. CasHLS-PO activity in the presence of PO inhibitors: 
thiourea, specific to POs [46]; and sodium azide for laccases [21] indicates that 
CasHLS-PO is likely to be a tyrosinase.  
Our data show that the molt stage does not significantly affect the number of 
hemocytes, in contrast to the previous reports in penaeid shrimps [97,98].  However, 




increase in the activity.  At late premolt, on the other hand, the CasHLS-PO activity is 
inverted with the THC, indicating that there may be some changes in the structure of 
hemocyte populations.  Crustacean hemolymph carries three types of hemocytes; 
hyaline, semigranular and granular hemocytes [37,82,96–98,115].  Yet, the hemocyte 
for PPO source has been conflicting [37,82,97,98] and the granules within 
semigranular and granular hemocytes contain the PPO [82,100,104,105].  
The levels of CasHLS-PO activity can be affected by the following factors: 1) 
levels of PPO expression and translation, 2) the number of PPO expressing 
hemocytes, 3) a relationship between the levels of PPO expression vs its translation, 
and 4) the levels of PPAE activity, in addition to the health status of animals.  In this 
study, we used the animals raised in the blue crab hatchery (Baltimore, MD) which 
were offspring of the brood females that had been pre-screened for typical diseases 
like Hematodinium [187] and a reo-like virus [188]. Our experimental crabs are 
considered healthy.  Thus, the changes in the CasHLS-PO activity during the molt 
cycle are considered intrinsic, naturally occurring physiological facts, not caused by 
infection(s) or disease(s).  
It has not been known in C. sapidus which type(s) of hemocytes express PPO, 
or if all the hemocytes have the same levels of PPO expression and PO activity 
during the molt cycle.  Furthermore, little is known for the translation rate of 
CasPPO-hemo and the half-life of CasPPO-hemo.  If all the hemocytes contain the 
same amounts of PPO expression and PPO, the levels of PO activity directly 
correspond to those of THC.  Instead, our results show in Fig. 7 reveal that this is not 




the hemocytes do not contain equal amounts of PPO expression and PPO.  Indeed, a 
specific type or types of hemocytes are responsible for CasPPO-hemo.   
Importantly, our data indicate that a specific type of hemocyte recruitment 
into the hemolymph may occur in a molt-stage dependent manner.  The molt cycle of 
crustaceans is controlled intimately by interactions between crustacean 
hyperglycemic hormone family and molting hormone, ecdysteroids [4,6,7,66].  It is a 
well-established fact in arthropods that elevated hemolymphatic ecdysteroids during 
premolt stage stimulate cell divisions in many tissues for their somatic growth and 
layering the new cuticle [6,189].  We infer that the increase in the numbers of THC 
may be driven by rising hemolymphatic ecdysteroid concentrations during premolt 
[190] and that ecdysteroids may trigger the proliferation of specific hemocytes.   
The different molt stages: early and late premolt and postmolt, have shown a 
slight increase in the THC, compared to those of preceding stages: intermolt, early 
premolt, and ecdysis.  The modest increase in the THC of the animals at early premolt 
showing elevated ecdysteroids [4,190] appears to be directly accounted for by the 
significantly elevated levels of PO activity.  This may be due to the fact that there 
may be a typical cell type containing the PO activity and increase in the translation 
rate of CasPPO-hemo.  The levels of CasPPO-hemo expression at these stages 
remain constant, compared to the other stages.  At the late premolt and postmolt 
stages, on the contrary, the amounts of elevated THC have no effect on the levels of 
PO activity as they are kept constant.  Thus, we suggest that these cells are not the 




Interestingly, the reduced THC at the ecdysis stage, compared to that at 
premolt reflects the decreased levels of PO activity.  And, a great degree of variation 
in the expression of CasPPO-hemo at this stage indicates a probable upregulation of 
PPO expression in these CasPPO expressing hemocytes.  This does not immediately 
affect PO activity, indicating that there is a differential regulation(s) between the 
transcription of CasPPO and its translation.  
Arthropod cuticles undergo dramatic, morphological, biochemical changes 
from softness to hardness during the molt cycle.  The newly laid cuticle-hardening 
process in crustaceans is generally known to occur during and immediately after 
ecdysis.  More specifically, however, it involves a two-sequential sclerotization 
process.  Firstly, the epicuticle being layered by the hypodermis at early premolt is 
completed its sclerotization at the late premolt [18].  And secondly, the deposition of 
exocuticle begins at premolt and is completely formed prior to ecdysis, the hardening 
of which takes place at the postmolt.  Thus, the hardening process of epicuticle and 
exocuticle clearly occurs at two different molt stages [2,18].  This allows the animals 
to stretch the soft cuticle of the body through  iso-osmotic water uptake during and 
immediately after ecdysis [8], resulting in somatic growth known as molt increment.  
Cuticle-hardening process that has been well documented in insects 
[11,17,21], is known to be hormonally regulated and to involve hemocytes and PPO.  
In C. sapidus, bursicon is known to stimulate the recruitment and granulation of 
hemocytes beneath the hypodermis at ecdysis stage [62], while the PPO transport 
from hemocytes to cuticle via the migration of hemocytes are reported in insects 




stage dependent and is found during the postmolt [37] and early and late premolt 
stages [38].  The low CasHLS-PO activity and THC at ecdysis might be a 
consequence of the recruitment of a specific type of hemocyte beneath the 
hypodermis for transport and allocation of PPO in the new cuticle as reported [37,62].  
The initial shell-hardening being a time-sensitive process, usually completes within 1-
1.5 hrs after ecdysis of C. sapidus.  We consider that the levels of PO activity 
provided by hemocytes might not be sufficient for the process.  Thus, it is plausible to 
suggest that there may be another tissue source of PPO, possibly hypodermis in which 
is also known to express PPAE during premolt [191]. 
 
2.6. Conclusion 
CasPPO-hemo with 2,806 nt encodes the putative 672 aa residue protein 
containing in the order of three conserved hemocyanin N, M, and C domains. The 
levels of CasPPO-hemo remain constant during the molt cycle. However, changes in 
the number of hemocytes and the PO activity residing in hemocytes during the molt 




Chapter 3: The involvement of hemocyte prophenoloxidase in 
the shell hardening of the new cuticle of the postmolt blue crab, 
Callinectes sapidus  
 
3.1 Abstract 
At each molt, cuticular structures of arthropods undergo dramatic changes 
from being soft to becoming hard.  The shell-hardening process of decapod 
crustaceans includes sclerotization and mineralization.  Hemocyte PPO plays a 
central role in the melanization and sclerotization particularly in wound healing in 
crustaceans.  However, its role in the crustacean initial shell-hardening process is 
much less investigated.  Based on earlier studies where heavily granulated hemocytes 
aggregated beneath the hypodermis during ecdysis, it was suggested they are involved 
in the shell-hardening process.  In order to determine if hemocytes and PPO have a 
role in the shell-hardening of crustaceans, a knockdown experiment using specific 
CasPPO-hemo-dsRNA was carried out using juvenile blue crabs, Callinectes sapidus.  
Multiple injections of CasPPO-hemo-dsRNA reduce specifically the levels of 
CasPPO-hemo expression by 57% and PO activity by 54% in CasHLS at the 
postmolt, with no changes in the total hemocyte numbers.  Immunocytocemistry and 
flow cytometric analysis with a specific antiserum generated against CasPPO show 
granulocytes, semigranulocytes and hyaline cells as the cellular sources for PPO at 
the postmolt.  Interestingly, the cellular sources of PPO vary by molt stage, together 
with the composition of hemocyte populations.  Throughout the molt cycle, 
granulocytes always contain PPO.  Semigranulocytes and hyaline cells become 




during postmolt, indicating that PPO expression in these cells may be involved in the 
shell-hardening process of the blue crab. 
 
3.2 Introduction 
Like all ecdysozoans, crustaceans undergo the molting process repeatedly 
during their life span in order to complete their growth, sexual maturation, and 
reproduction [1,2].  Successful molting is precisely coordinated through interactions 
of multiple hormones and neurohormones [4–8].  The newly laid cuticle that is 
synthesized by the hypodermis at premolt is soft and pliable and allows the expansion 
of the body through the uptake of isosmotic water at ecdysis [1,2,144,192,193].   
The hardening process of the crustacean new cuticle is complex and primarily 
involves  two sequential processes: sclerotization and mineralization 
[11,12,14,15,18].  The sclerotization occurs in the new soft and pliable cuticle 
immediately after  ecdysis [70,73,194].  Mineralization as the second step involves 
the incorporation of calcium carbonate into the protein matrices of the cuticle  2.5 hrs 
after ecdysis  [15,16,18,69,70,75,195–197].  
In insects, sclerotization involves both prophenoloxidases (PPOs) and laccases 
that cross-link chitinous to protein fibers in the matrix of the cuticle through the 
oxidation of phenol substrates [11,12,17,21,198].  In decapod crustaceans, there is no 
report on the presence of laccase, whereas PPO present in hemocytes is primarily 
known for immunity responses [39,41,43,80,93,132].  However, earlier studies 
suggest that  hemocytes may be involved in the shell-hardening process in 




beneath the hypodermis during ecdysis [37,38].  These findings may suggest that 
crustacean PPO may be transported into the new cuticle for sclerotization [37,38], 
similar to that found in insects [25,30]. 
Three types of hemocytes are found in the hemolymph of decapod crustaceans 
[82,100,104]: granulocytes (G); semigranulocytes (SG); and hyaline cells (H).  With 
the major function of PPO in the immune response, its cellular source varies by 
species and molt stage.  It is reported that Gs and SGs are the exclusive PPO sources 
at the intermolt of Homarus americanus, Panulirus interruptus, Loxorhynchus 
grandis, Pacifastacus leniusculus, Penaeus japonicus, Procambarus clarkii, and 
Scyonia ingentis [82,98,100,105,115].  The Hs are the source of PPO during the 
ecdysis of Uca pugilator [37].  Nevertheless, Gs contain the PO activity in P. 
interruptus and L. grandis, a small group of Hs was found also showed PO activity 
[82].  With the differences in the cellular sources, PPO may be produced by a specific 
cell type at different molt stages. 
Interestingly, the total hemocyte numbers and their PO activity vary during 
the molt cycle of Callinectes sapidus [95].  This suggests that PO activity may be 
derived from different types of hemocytes.  Specifically, the initial shell-hardening 
process may be regulated by the PPO that is expressed in the hemocytes only at 
postmolt.   
Herein, we report that during the molt cycle, there are changes in the types of 
hemocytes that are responsible for PPO expression.  The role of hemocyte PPO in the 
shell-hardening process is defined with RNAi experiments, specifically using a 




determined the effects of dsRNA injections on the transcript levels of CasPPO-hemo 
by a qPCR assay and protein levels in hemocytes using immunocytochemistry (ICC) 
and flow cytometry.  More importantly, the cuticle hardness of these animals has 
been measured. 
 
3.3 Materials and Methods 
3.3.1 Animals 
Juvenile C. sapidus crabs (15-30 mm carapace width, CW) were obtained 
from the blue crab hatchery [Aquaculture Research Center, the Institute of Marine 
and Environmental Technology (IMET), Baltimore, MD].  The animals were reared 
in individual compartments in recirculated, aerated artificial seawater (25 ppt; 22ºC) 
as described [62,158,159].  Juveniles with ~80-90 mm CW were molt-staged for 
experiments by following the criteria as described [160].  All animals were at 
intermolt stages, unless stated otherwise.  Male and female crabs were used 
randomly. 
3.3.2 Identification of hemocyte types in the hemolymph of C. sapidus 
First, in order to identify hemocyte types, hemolymph of the animals at 
various molt stages were collected in a fixative (4% PFA in 10 mM cacodylate 
buffer) as described [95] at 1:1 ratio (v:v).  Hemolymph smears were prepared as 
described [100] and stained with hematoxylin (1 min) and eosin (4 sec).  Then they 
were observed immediately and photographed under a compound microscope 




the cellular diameters (mean ± SE µm), with an assumption that cells are round.  The 
hemocyte types were identified by following the criteria as stated [100,104].  In brief, 
the properties of these cells were detailed as listed in Table 2. 
The types of hemocytes present in juvenile hemolymphs at different molt 
stages (n=6-18) were also identified using flow-cytometry.  Fixed hemocytes were 
stained with SYBR-Green I (2X) nucleic acid staining (FMC BioProducts) as 
described [199] at 1:100 ratio (v:v = SYBR-Green I:sample).  After 10 min 
incubation at RT, 50 μl of each sample was analyzed using a C6 CFlow flow-
cytometer (Accuri Cytometers), with setting at a media fluidic rate (35 μl/min) and a 
core size of 16 μm at FL1-H and SSC-H.  The types of hemocytes were characterized 
by their sizes (FSC-H) and cytosolic complexities and granularities (SSC-H). 
3.3.3 Production of a rabbit-anti-CasPPO-hemo serum 
Two peptides that were modified by adding ‘C’ at C-terminus: 
V421ESRGQKNQL430C and V199SRDRKGELF208C of the putative CasPPO-hemo 
(GenBank AGE48302.1) were synthesized (Peptide 2.0 Inc).  These two regions were 
selected to increase the antiserum specificity by excluding the hemocyanin domains 
and to enhance the immunogenecity by including the surface of PPO (Phyre2; 
http://www.sbg.bio.ic.ac.uk/phyre2/).  Two different conjugation methods were 
carried out: m-maleimidobenzoyl-N-hydroxysuccinimide ester (MBS) conjugating 
the petides to bovine thyroglobulin (bTG, Sigma) at a molar ratio of 50:1:15 (peptide: 
bTG: MBS) and 1-Ethyl-3-[3-dimethylaminopropyl]-carbodiimide hydrochloride 
(EDC) at a molar ratio of 50:1:560 (peptide:bTG: EDC) [200].  At the end of 




and lyophilized for the antiserum production (ProteinTech).  The remaining 10% was 
dried in a SpeedVac (Jouan) and used for pre-absorption controls.  The rabbit 
antiserum (α-CasPPO-hemo) was further characterized in terms of a dilution factor, 
specificity and cross-reactivity using western blot analysis with hemocytes lysate 
supernatant (HLS) (Suppl. Figs. S1-S2; Suppl. Protocol S1) [201]. 
3.3.4 Determining CasPPO-hemo function in the initial shell-hardening process using 
dsRNA 
3.3.4.1 In vitro transcription of CasPPO-hemo-dsRNA 
The template for dsRNA was generated by amplification of hemocyte cDNA 
with double-strand (ds) CasPPO-hemo primers (Table 3).  The template dsRNA 
amplification region of CasPPO-hemo was selected based on its specificity by being 
free of hemocyanin domains.  After purification using these PCR products (243 bp), 
the template was in vitro transcribed using a TranscriptAid™ T7 High Yield 
Transcription kit (Fermentas) as described [202].  Prior to injections, CasPPO-hemo-
dsRNA were dissolved in 0.2 µm filtered crustacean saline solution containing phenol 
red at 0.001% [203] to give a final concentration at 0.1 µg/µl  Phenol red was added 






Table 2. Properties of the different hemocyte types of C. sapidus and other decapod 
crustaceans 
Hemocyte type 
Characteristics under a light 
microscope 
Reference 
Granulocytes Contain many large and a few 
small granules. Spindle, around 
or oval form  
Wenli and Shield, 
2007 (C. sapidus) 
 Large eosinophilic granules. Low 
nuclear/cytoplasmic ratio. Mainly 
spherical shapes. The granules 
present in various degree of 
density that were compacted or 
fused into a homogeneous matrix 




Contain many small and a few 
large granules. Morphology 
varies: spindle, oval or round 
shape. Cell sizes vary from 12 to 
20 um. 
Wenli and Shield, 
2007 (C. sapidus) 
 Presence of small, round or 
slightly oval, eosinophilic 
granules. Ovoid and fusiform 
cells. Low nuclear/cytoplasmic 
ratio. Round or spindle shape, but 
most often oval. 
Lanz et al., 1993 
(P. clarkii) 
Hyaline cells Contain a few or no granules in 
the cytoplasm. Cells have a 
spindle or round form. Cell sizes 
with 9 -18 um diameter. 
Wenli and Shield, 
2007 (C. sapidus) 
 Pleomorphic: flat pseudopodia 
normally extending from the 
hemocyte surface. Cytoplasm 
without granules and high to low 
nuclear/cytoplasmic ratio. 
Nucleus with well-defined 
heterochromatin. 






3.3.4.2 Effects of multiple injections of CasPPO-home-dsRNA on shell-hardness at 
postmolt animals 
3.3.4.2.1 Levels of CasPPO-hemo gene expression 
The role of CasPPO-hemo in shell-hardening was examined using multiple 
injections of CasPPO-hemo-dsRNA.  The crabs at intermolt stage (85.5 ± 2.3 mm 
CW, n=7) were injected with 10 µg CasPPO-hemo-dsRNA every other day until 
ecdysis (20-28 total injections).  Control animals (88.0 ± 2.1 mm CW, n=7) were 
injected with 100 μl of crustacean saline.  In order to determine the levels of PPO and 
PO activity at postmolt, hemolymph samples were collected after crabs completed the 
expansion of the body, at the half of early postmolt [194] (~24 hrs after ecdysis).  The 
hemolymph samples (400 μl) were collected at 4oC for RNA extraction [95] and 
hemocyte lysate supernatant (HLS) as described [95] (see below).  The expression 
levels of CasPPO-hemo were estimated using qPCR assay with Fast SYBR Green 
Master Mix (Applied Biosystem) on a 7500 Fast Real-Time PCR System (Applied 
Biosystem).  The procedures for qPCR standards were as described in [95].  The 
qPCR primers are listed in Table 3. 
 
Table 3. List of primers used for dsRNA template amplification and qPCR assay 









3.3.4.2.2 Levels of CasHLS-PO activity and CasPPO-hemo protein expression 
The PO activity of Callinectes HLS (CasHLS) was determined as described 
[95].  The data are shown as mean ± SE (n=6-7) of PO activity (OD/mg HLS). 
For determining levels of CasPPO-hemo protein in hemocytes, hemolymph of 
the experimental animals at 24 hrs after ecdysis were withdrawn (100 µl) directly into 
a 1 ml syringe containing a fixative (4% PFA in 10 mM cacodylate buffer) [95] at 1:1 
ratio (v:v).  The contents of CasPPO-hemo in hemocytes were analyzed by the 
fluorescent intensity of the positive signal by α-CasPPO-hemo through an ICC 
analysis (described below) using ImageJ [204].  The ICC sample images were taken 
using the same settings.  The hemocytes were also analyzed for cytosolic complexity 
using a C6 CFlow flow-cytometer (Accuri Cytometers).  Additionally, CasPPO-hemo 
was detected in CasHLS using a western blot analysis (Suppl. Protocol S1). 
3.3.4.2.3 Hardness of postmolt cuticle 
After ecdysis, the cuticle hardness of each crab was measured using a hand-
held Shore-type durometer (00 gauge, Instron) as described [62,195] for 48 hrs after 
ecdysis the period which includes all early postmolt stages as described [194].  The 
hardness of the carapace was measured in the mesogastric area (Suppl. Fig. S2).  
Because the rates of hardening vary depending on the area of cuticle [195], the 
hardness was measured at 6-8 different areas from each animal and averaged.  The 




3.3.5 Differential hemocyte counting during the molt cycle 
The differential hemocyte type counting (DHC) and total hemocyte counting 
(THC) were obtained by flow cytometric analysis.  The hemocytes (as above) from 
juvenile blue crabs at different molt stages (n=6-18) were stained with SYBR-Green I 
(2X) nucleic acid staining (FMC BioProducts) as described previously [199].  The 
types of hemocytes were characterized by their sizes (FSC-H) and cytosolic 
complexities (SSC-H).  The data are presented as mean ± SE (number of cells/ml 
hemolymph). 
3.3.6 Identification of CasPPO-hemo in hemocytes during the molt cycle 
3.3.6.1 Immunocytochemistry (ICC) 
Hemolymph (50 µl) was sampled (n=5-6) as described above and centrifuged 
for hemocyte isolation [95].  The pelleted hemocytes were resuspended in 50 μl of 
fixative solution (4% PFA in cacodylate buffer 10mM, pH 7.1).  A drop of the 
samples (~5-8 μl) was smeared on a slide glass and dried for 20-30 min at RT [205].  
These slides were immersed in methanol for 30s, rinsed in milliQ water and incubated 
for 10 min in PTX1 solution (PBS containing 0.25% Triton X-100 and 5% dimethyl 
sulfoxide, DMSO) [205,206]).  After rinsing with milliQ water three times (5 min 
each), the slides were blocked with blocking buffer (PTX 1 containing 2% BSA) 
overnight at 4ºC.  Then, the slides were incubated with α-CasPPO-hemo serum (1:200 
dilutions in the blocking buffer) for 30 min at RT and were immediately washed 5 
times in PBS (5 min each).  The incubation with Alexa Flour goat anti-rabbit IgG 




darkness.  After washing 5 times in PBS, the slides were briefly post-fixed in the 
fixative solution and washed twice with PBS.  Finally, the slides were mounted with a 
ProLong Gold antifade reagent with DAPI staining (Life Technology).  The 
hemocytes were examined for their subtypes under a fluorescent microscope 
(Axioplan, Zeiss) and images were captured with a digital camera (AxioCam MRc, 
Zeiss).  Staining intensity were further analyzed and calculated using Zen 2012 and 
ImageJ [204]. 
As for the pre-absorption control, synthetic CasPPO peptides (10 nmol each) 
were incubated with α-CasPPO-hemo serum (a final dilution at 1:10) overnight at 4ºC 
through gentle mixing on a magnetic stirrer.  It was then diluted to a final dilution of 
1:200, the same as the α-CasPPO-hemo serum.  
3.4.6.2 Flow cytometry analysis 
The hemocytes collected from the crabs at intermolt (n=8) and postmolt (n=6) 
stages were fixed and washed in 1 ml PTX2 (0.1M phosphate buffer containing 0.5% 
Triton-X and 2% BSA; DMSO is removed from the buffer solution improving cell 
suspension in the samples for flow-cytometry) and incubated for 15 min at RT for 
blocking.  Then, the hemocytes were centrifigued (800 g for 10 min, 4ºC) and 
incubated in α-CasPPO-hemo solution similar to that of ICC (1:200 dilutions, using 
200 μl PTX2 + 2% BSA) for 30 min at RT [207].  Afterwards, the samples were 
washed twice in 1 ml Dulbecco’s Phosphate Buffer Saline, PBSG as described in 
[207], gently pipetting up-down and living in a rotational shaker for 5 min.  The 
incubation with the secondary antibody, Alexa Fluor goat anti-rabbit IgG (Life 




PTX2).  The samples were then washed once in 1 ml PBSG, and finally resuspended 
in 100 µl PBSG.  Forty μl of each sample were read in a C6 CFlow flow-cytometer 
(Accuri Cytometers) under the conditions described above. 
In each case, fixed hemocytes were washed once and resuspended in 100 μl 
PBSG as negative controls.  The positive staining of hemocytes with α-CasPPO-hemo 
serum were established and confirmed with negative controls and validation beads 
that have been provided by the manufacturer (Spherotech 8-Peak Validation Beads 
FL1 - FL3, BD Accuri). 
3.4.7 Statistical analysis 
All data were subjected to normality test using Kolmogorov-Smirnov test and 
the homogeneity of variances by Cochran C test (Statistica 7.0, StatSoft., Inc).  
Statistical significance of one way ANOVA was accepted at P < 0.05 and post-hoc 
Tukey test was adopted to distinguish the source of variation among the molt stages.  
The data are presented as mean ± SE (n), where n is the number of crabs.  For shell-






Figure 9. Effects of multiple CasPPO-hemo-dsRNA injections (20-28 
injections) on the shell-hardening process.  (A) Levels of CasPPO-hemo 
expression in hemocytes and (B) CasHLS-PO activity during postmolt (24 hrs 
after ecdysis).  CasAK is used as reference gene in the expression analysis.  
Different letters and asterisk denote significant differences at P < 0.05 (n=7).  
C) The western blot analysis on the experimental samples identifies CasPPO-
hemo in CasHLS.  D) Shell-hardness of the new cuticle during 48 hrs after 
ecdysis.  The hardness of the postmolt cuticle was measured by a hand-held 
durometer (durometer scale = 0-100 DU).  Dashed line = CasPPO-hemo-
dsRNA injected group (R2 = 0.92) and solid line = control group (R2 = 0.90).  
ANCOVA analysis show significant differences (P < 0.05; n=7).  HD50 was 






3.4.1 Identification of hemocyte types in the hemolymph of C. sapidus 
Three types of hemocytes are identified in C. sapidus hemolymph: 
granulocytes (G), semigranulocytes (SG) and hyaline cells (H) (Suppl. Figs. S3A-B).  
Gs contain cytoplasmic granules with a nucleus in their center and the average 
diameters of cells with 12.0 ± 1.5 μm (n=35).  SGs are smaller than Gs, with 
diameters of 9.2 ± 1.1 μm (n=35).  They also show their nuclei in the center of the 
cytoplasm and contain fewer cytoplasmic granules, compared to those present in Gs.  
Hs are the smallest hemocytes with diameters of 8.5 ± 1.1 μm (n=35) but show a 
prominent nucleus in the center of the cytoplasm but without cytoplasmic granules  
 
3.4.2 Determining CasPPO-hemo function in the initial shell-hardening process using 
dsRNA 
Both CasPPO-hemo-dsRNA and control group do not show significant 
differences in the size and number of the hemocytes and molt increment and intervals 
(Suppl. Fig. S4; Suppl. Table S1). 
The multiple injections of CasPPO-hemo-dsRNA reduce both its transcription 
in hemocytes by ~57% (Fig. 9A; Fig. S5) and protein levels with ~54% of the 
CasHLS-PO activity (Fig. 9B-C), compared to controls.  
During 48 hrs after ecdysis, the animals that received the CasPPO-hemo-
dsRNA show the shell-hardening process significantly slower than the controls (Fig. 
9D).  During the first ~2 hrs after ecdysis, the cuticle of CasPPO-hemo-dsRNA 




(n=7).  At 24 hrs after ecdysis, the CasPPO-hemo-dsRNA injected crabs increase the 
hardness to 51 ± 2 DU (n=7) , while the controls have 84 ± 5 DU (n=7).  At 48 hrs 
after ecdysis, the hardness of the carapace is 82 ± 2 (n=7) and 95 ± 2 DU (n=7) for 
the CasPPO-hemo-dsRNA and control groups, respectively. 
As shown in Fig. 9D, the values of HD50 (time after ecdysis when the cuticle 
reach the 50% of hardness) significantly differ with 18.9 ± 1.4 hrs (n=7, P < 0.05) for 
CasPPO-hemo-dsRNA group and 8.7 ± 0.9 hrs (n=7) for control group.  
In CasPPO-hemo-dsRNA injected animals, the hemocytes collected at 24 hrs 
after ecdysis display significantly reduced staining intensities with α-CasPPO-hemo 
(Figs. 10A-B), specifically in SGs and Hs, compared to those of controls.  The flow-
cytometry analysis (Fig. 10C) of hemocytes signifies the presence of three different 
cell types.  In CasPPO-hemo-dsRNA, the cytosolic complexity and granularity do not 






Figure 10. Levels of CasPPO-hemo in hemocytes after multiple injections of 
CasPPO-hemo-dsRNA.  (A) Fluorescent intensity analysis, (B) ICC and (C) 
flow-cytometric analysis of hemocytes from control and CasPPO-hemo-dsRNA 
group.  The fluorescent intensity analysis was calculated by ImageJ using the 
positive staining by α-CasPPO-hemo serum in each type of hemocyte 24 hrs 
after ecdysis, as a reference for PPO content.  The insertion in the ICC pictures 





Figure 10. (From the anterior page) The flow-cytometry indicates no changes 
in the cytosolic complexity and granularity of hemocytes in the CasPPO-hemo-
dsRNA injected group respect to the control.  Cytosolic complexity (SSC-H) is 
shown as mean ± SE (n=4-5).  Different letters indicate significant differences 
at P < 0.05, two way ANOVA (B) and Student’s t test (C).  Bar scale = 10 µm. 
G= granulocytes, SG= semigranulocytes, H= hyaline cells. 
 
3.4.3 Differential hemocyte counting (DHC) during the molt cycle 
Callinectes hemolymph always carries three types of hemocytes throughout 
the molt cycle.  The total hemocyte counting (THC) does not show significant 
differences (one way ANOVA; P > 0.05) but the number of each cell types (DHC) 
vary significantly during molt cycle.  At intermolt, the THC ranges 6.2 ± 1.9 x106 
cells/ml hemolymph (n=6) and increases up to 14.1 ± 3.0 x106 cells/ml hemolymph 




are Hs with 4.3 ± 1.4 x106 cells/ml hemolymph.  SGs are the second major type in 
this stage, with 1.6 ± 0.5 x106 cells/ml hemolymph and Gs are 0.3 ± 0.1 x106 cell/ml 
hemolymph. 
 
Figure 11. Differential counting of hemocytes during the molt cycle of the blue crab 
using the flow-cytometry analysis.  The THC (solid line) does not show significant 
differences among the molt stages.  n.d. = no significant difference; the “*” denotes 
significant difference at P < 0.05, two way ANOVA. 
 
 
From early premolt and late premolt, THC in the hemolymph increases to 11.0 
± 1.7 x106 cells/ml hemolymph and 14.0 ± 3.0 x106 cells/ml hemolymph, 
respectively.  The composition of hemocyte types throughout premolt (early and late 
premolt) in the hemolymph changes.  SGs (~65% of THC) and Gs (~30% of THC) 
are the majority in hemocytes and Hs represent ~6% of THC.  Compared to intermolt 
and postmolt, a significant reduction in numbers of Hs is accounted for only 0.6 ± 0.1 
x106 cells/ml hemolymph at early premolt and 1.0 ± 0.3 x106 cells/ml hemolymph at 




± 1.2 x106 cells/ml hemolymph and 3.1 ± 0.5 x106 cells/ml hemolymph respectively.  
Both hemocyte types increase between 1.3-1.5 fold at late premolt (Fig. 11 and Table 
4).  At ecdysis, THC is reduced to 7.9 ± 1.7 x106 cells/ml hemolymph but the 
composition of hemocyte types remains the same as both premolt stages. 
At postmolt, THC consists of all three hemocyte types at close contribution 
(Fig. 11).  Compared to ecdysis, the number of Hs significantly (P <0.05) increases to 
4.2 ± 1.6 x106 cells/ml hemolymph (~41% of THC).  SGs are constant in their 
numbers, although significantly (P <0.05) low compared to premolt.  Gs represent 
~20% of hemocyte with 2.0 ± 0.7 x106 cells/ml hemolymph. 
 
Table 4. Changes in different of cell types in hemocyte populations of the hemolymph 
of C. sapidus during the molt cycle. Significant differences by ANOVA (P < 0.05). 
Different letter represent significant differences at each molt stage. 
 Intermolt E. premolt L. premolt Ecdysis Postmolt 
H 69.9 ± 22.6 a 5.9 ± 1.2 a 6.8 ± 2.3 a 6.0 ± 1.3 a 41.4 ± 15.5 a
SG 25.8 ± 7.9 a 64.7 ± 10.9 b 60.5 ± 15.8 b 60.7 ± 14.4 b 39.0 ± 15.0 a
G 4.2 ± 2.0 b 29.4 ± 4.9 c 32.8 ± 4.4 c 33.4 ± 6.3 c 19.6 ± 6.7 a
Relative abundance (Mean ± SD %, Intermolt, late premolt and postmolt: n=6; Early premolt: n=18, 
Ecdysis: n=7). H = hyaline cells; SG = semigranulocytes; G = granulocytes. 
 
3.4.4 Immnunostaining of CasPPO-hemo in each type of hemocytes during the molt 
cycle 
The presence of CasPPO-hemo protein in hemocytes is examined using ICC 
and flow cytometry.  ICC results show that Gs displays the strongest immunostaining 
with α-CasPPO-hemo serum through molt stages (Figs. 12A-B; n=5-6).  Hs have 
immunostaining only at postmolt (Figs. 12A-B; n=5-6) while SGs are 







Figure 12. Identification of CasPPO-hemo in hemocytes during the molt cycle of the 







Figure 12. (From the previous page)  Identification of CasPPO-hemo in 
hemocytes during the molt cycle of the blue crab.  Immunostaining of 
hemocytes at different molt stages using a specific α-CasPPO-hemo serum.  Gs 
contain PPO during all the molt cycle, while SGs and Hs show a PPO protein 
expression which is molt stage dependent.  Signals: + PPO and – PPO.  A) ICC 
(n=5–6) and B) fluorescent intensity of the positive signal of α-CasPPO-hemo 
staining, using ImageJ. C)  Immunostaining of CasPPO-hemo by flow-
cytometry analysis: At intermolt stage, ~14% of hemocytes are PPO positive 
while at postmolt, the PPO positive hemocytes are over 90% (n=5-8).  Scale 






The flow-cytometry analysis (Fig.12C; n=6-8) with immunostained 
hemocytes is in agreement with ICC.  At intermolt ~14% of the cells are positive 




This study provides evidence that PPO present in hemocytes is an essential 
component in the shell-hardening process of C sapidus.  Further, PPO is expressed in 
different hemocyte types during the molting cycle of C. sapidus.  At postmolt, SGs 
and Hs are the source of PPO, while at intermolt, Gs are the major type of cells that 
produce PPO. 
Our data show during the molt cycle that changes in the number of cell types 
are consistent to the levels of hemocyte population [95].  The hemolymph of C. 
sapidus always carries three types of hemocytes throughout the molt cycle, as similar 
to that found in other crustacean species including H. americanus, P. interruptus, L. 
grandis, P. leniusculus, P. japonicus, P. clarkii, U. pugilator and S. ingentis 
[37,82,98,100,105,115].   
To define the direct role of CasPPO-hemo in the shell-hardening process in C. 
sapidus, the animals have been injected with CasPPO-hemo-dsRNA.  Multiple 
injections of dsRNA have been employed to define the functions of a gene of interest 
in several crustacean species [53,58, Techa and Chung, in press].  The dsRNA 
injected crabs show significantly reduced levels of CasPPO-hemo transcripts and 




importantly, the animals treated with CasPPO-hemo-dsRNA have significantly slower 
shell-hardening process than controls.  
Since the hemolymph of C. sapidus contains three types of hemocytes 
[96,104], the following question was asked: Which hemocyte type(s) that produce 
PPO is/are affected by dsRNA injections at postmolt?  Isolating each cell type may 
result in the loss of cells [209].  In this study, the values of THC that have been re-
examined using flow cytometry are in agreement with the levels obtained by cell 
counting using a hemocytometer [95].  Hence, the cell population present in the 
hemolymph are determined using flow-cytometric analysis, combined with the ICC 
with a specific α-CasPPO-hemo serum and the three cell types, showing distinctive 
properties as previously stated [104].   
PPOs contain three homocyanin domains: N, M and C [95].  In order to 
increase antiserum specificity, CasPPO antiserum has been generated against two 
regions located between the hemocyanin N and M domains and between hemocyanin 
M and C domains of CasPPO [95]. α-CasPPO-hemo serum recognizes ~0.6 µg HLS 
(= ~900 hemocytes equivalent) at a final dilution of 1:2000 (Suppl. Fig. S2).  The pre-
absorption controls show no staining in the cells.  
Multiple injections of CasPPO-hemo-dsRNA affect the cell types but differ in 
the staining intensities at postmolt.  In both SGs and Hs, the most significantly 
reduced CasPPO-hemo immunostaining intensities are found.  In the Gs, the staining 
intensities remain similar to those of controls and no significant differences in its 




Our data suggest that specific hemocyte types may be recruited into the 
hemolymph of a specific molt stage.  This indicates that hematopoietic activity may 
inherently differ by a molt stage.  Interestingly, a molt stage-dependent pattern of 
hemocyte production has been demonstrated in the crustacean hematopoietic organs, 
together with increments changes  of its mitotic rates during premolt [97] resulting 
primarily in the release of Gs.  It is unknown what triggers such differences in 
hematopoietic activities during the molt cycle.  When considered that the elevated 
concentrations of ecdysteroids in the hemolymph stimulate cellular mitotic activity in 
the tissues [6,189,210,211], they may also affect the activity of hematopoietic organs.  
On the other hand, the role of small cell signaling molecules in hemocyte 
proliferation is known [116,212].  Astakines 1, an invertebrate cytokine expressed in 
the hematopoietic organs and hemocytes, promotes the proliferation and 
differentiation of hemocyte in P. leniusculus [116,212].   
Our earlier study shows that hemocytes are aggregated beneath the 
hypodermis immediately after ecdysis [62].  The fact that the transport of PPO from 
hemocytes into the cuticle has been suggested in insects [38] indicates that these 
hemocyte PPOs may play a similar role in shell-hardening in crustaceans, as reported 
in insects.   
At postmolt, all types of hemocytes are a rabbit anti-CasPPO-serum positive.  
Hs, which are positively immunostained only at postmolt suggest that there may be a 
particular function for these hemocytes after ecdysis.  This suggestion is closely 
related to the observation made in U. pugilator [37], reporting that Hs were PPO 




hemocytes that mediate the shell-hardening in the fiddler crab.  It is notable that Hs 
and SGs show reduced PPO contents when the expression of CasPPO-hemo is 
knocked-down, by the injection of dsRNA. 
The hemocytes may undergo inherent changes in their functions during the 
molt cycle (Fig. 4B), although the life span of each cell is unknown.  The staining 
intensities of PPO noted in the Gs and hemocyte types vary with molt stage, 
suggesting that PPO activities are contributed by different cell types at a given molt 
stage.  In the shell-hardening process at postmolt, when crabs are injected with 
CasPPO-hemo-dsRNA, SGs and Hs reduce their total PPO contribution to ~19% and 
~65% (respectively) lower than the total PPO that may be contributed by Gs.  In 
contrast to the dsRNA injected animals, in the control, Hs and SGs represent the major 
contribution of PPO. 
However, SGs may also be PPO positives during the intermolt stage and 
increasing its PPO contribution.  The flow-cytometry shows ~14% of hemocytes are 
PPO positive at intermolt.  At this stage, SGs and Gs are equivalent ~30 ± 8% of 
THC.  Nonetheless, the differentiation of hemocyte types by flow-cytometry is based 
on internal complexity (SSC-H) and size (FSC-H) of the cells, therefore, Gs and SGs 
might have been under- or overestimated.  SGs have been found PPO positive during 
the intermolt of other crustacean species [82,98,100,105,115].  On the other hand, the 
ICC shows Gs as the PPO positive hemocytes at the intermolt stage, implying that Gs 




Immediately after ecdysis the final expansion of the body is completed and a 
rapid hardening is required.  The transport and delivery of PPO into the new cuticle 
should not be delayed and happened during and after completion of ecdysis.   
The contribution of each type of hemocytes toward total PPO is different by a 
molt stage, which indicates that the hematopoiesis involves a molt stage-specific 
hemocyte differentiation.  Patterns of hematopoietic production and release of 
hemocytes vary during the molt cycle [97].  Within the hematopoietic tubules, the 
hemocytes are differentiated to a specific type of mature cells [102,117,123,213].  
However, functional differentiation of these hemocytes by expressing PPO is 
completed by their release into the hemolymph [102,115].  Similar upregulation of 
PPO occurs when the animals respond to immune challenges [39,80,214–216].  One 
may argue that our animals might have been infected.  Specifically, the immunity role 
of Hs has been reported as phagocytosis, while Gs are the reservoir of the humoral 
defense as the PPO cascade system [115,125,209,217].  However, we used hatchery-
raised animals that are considered healthy as they have been reared in controlled 
conditions and the broodstock have been screened from known diseases [187,188].   
This study clearly shows that hemocytes respond to chemical cues or 
pathogens that are present in the hemolymph including ecdysteroids, cytokines 
[119,218] and hormones in the hemolymph upregulating PPO.  Further study is 
warranted, specifically isolating the naïve differentiated hemocytes from the 
hematopoietic tubules and recognizing newly released hemocytes (for example by 
bromodeoxyuridine, BrdU, [102]) may provide information to answer if hemocytes 




The levels of CasPPO-hemo transcripts remain constant during the molt cycle 
[95], but little is known about the translation rate of CasPPO-hemo or the half-life of 
the protein.  Differences in levels of immunostaining, detected in a same type of 
hemocytes during the molt cycle, may suggest differential translation rates.  Using Gs 
as an example, ~2.5 x 105 Gs/ml hemolymph represent ~3.0 x 105 transcripts of 
CasPPO-hemo at intermolt.  At postmolt, 2.0 x 106 Gs are equivalent to 1.7 x 104 
transcript copies.  The expression per each G is 1.2 and 0.009 (transcripts/cell/ml 
hemolymph) at intermolt and postmolt respectively.  If all hemocytes express 
CasPPO during ecdysis, the equivalent transcripts per type of hemocyte correspond 
to: Hs = 0.7 x 105, SG = 7.4 x 105, and Gs = 4.1 x 105 CasPPO-hemo copies.  
Surprisingly, the expression per cell, in each hemocyte type, is the same ~0.15 
(transcripts/cell/ml hemolymph).  Moreover, if there is a constant transcription-
translation for the amounts of immunoreactive PPO in the stained hemocytes, a value 
for translation can be extrapolated.  At ecdysis, even though Hs represent 6% of the 
THC, they show the highest level of intensity per transcripts (0.1 intensity 
units/CasPPO-hemo transcripts), while SG and Gs show 0.01 and 0.03 % 
respectively. 
Hs may pass easily through the hypodermis to rapidly distribute the PPO into 
the new cuticle and quickly initiate the shell-hardening during postmolt.  Hemocyte 
tissue infiltration is a process that has previously been reported in crustaceans 
[80,133]. 
Taken all together, a model is proposed integrating hemocytes and CasPPO-




estimated as the main hemocyte types during premolt stages.  Premolt is the 
preparation for ecdysis through the synthesis of the pre-ecydsial layers of the new soft 
cuticle [2,18], which is induced by the increase in the levels of hemolymphatic 
ecdysteoids [4,6].  The positive detection of PPO in SGs and Gs at early premolt may 
be associated with the preparation for ecdysis, which may include the PPO transport 
that has been suggested  [38].  The sclerotization occurring during the first hours after 
ecdysis involve the hemocyte characteristics observed during postmolt, when all 
hemocytes are PPO positive.  It appears that Hs and SGs may likely be involved in 
the shell-hardening process at the postmolt, while Gs, as the constant PPO reservoir 









Figure 13. A proposed model for the functional involvement of hemocytes and 
its PPO (CasPPO-hemo) in the shell-hardening process of the blue crab C. 
sapidus.  The diagram summarizes the results obtained from the current study. 
Changes in hemocyte numbers are shown with bar plots. The positive (+) and 
negative (-) symbols indicate the presence or absence of PPO expression in each 
type of hemocytes, respectively.  Blue arrows indicate the potential transport of 
PPO from hemocytes into the cuticle, as described [38].  Red arrows indicate the 
suggested hemocytes and PPO role in the immunity system [39,40].  Asterisks 






3.6 Supplemental Tables and Figures 
3.6.1 Supplemental Tables 
Supplemental Table S1. Hemocyte abundance (cells/ml hemolymph) 24 hrs after 
ecdysis in CasPPO-hemo-dsRNA injected crabs and control group. No significant 
differences (P > 0.05) are observed by two way ANOVA. 
 
Hemocytes dsRNA (n=5) Control (n=4) Significance 
Granulocytes 8.8 ± 3.1 x 105 6.6 ± 2.3 x 105 P > 0.05 
Semigranulocytes 1.7 ± 0.6 x 106 2.1 ± 0.5 x 106 P > 0.05 
Hyaline cells 1.4 ± 0.7 x 106 1.8 ± 0.6 x 106 P > 0.05 
Total 5.5 ± 1.9 x 106 5.2 ± 1.7 x 106 P > 0.05 
 




Supplemental Figure S1. Saturated ammonium sulfate (SAS) precipitations of 
proteins present in hemocytes (HLS) and its PO activity isolation.  A) The PO 
activity was recovered in % saturation of ammonium sulfate.  (B) The 
Identification of CasPPO-hemo in the SAS fractions was performed by western 







Supplemental Figure S2. The properties (sensitivity and a dilution factor) of α-
CasPPO-hemo antiserum are determined using western blot analysis with 
HLS30%SAS.  A) Western blot using the antiserum at 1:2000 dilution. B) 
Differential α-CasPPO-hemo dilutions. Pre-Abs = pre-absorption control. For 
Pre-Abs, synthetic CasPPO peptides (10 nmol each) were incubated with α-
CasPPO-hemo serum (a final dilution at 1:10) for overnight at 4ºC through 
gentle mixing on a magnetic stir.  It was then diluted at a final dilution of 





Supplemental Figure S3. Sampling areas of the shell hardness at postmolt.  The 
hardness is measured on 6 spots (white dots) located of dorsal carapace 
mesogastric area of the blue crab (between dashed lines) using a durometer.  








Supplemental Figure S4. Hemocyte types differentiation.  Morphological 
differentiation of the blue crab hemocyte by A) microscopy (H&E = 
hematoxylin and eosin staining) and B) flow cytometry.  The differentiation is 
made, based on the criteria as described [100,104].  Three main types of 
hemocytes are recognized during the molt cycle:  Granulocytes (G), 
semigranulocytes (SG) and hyaline cells (H). Hemolymph is collected in a 






Supplemental Figure S5. Effects of CasPPO-hemo knockdown experiment in 
the body size (molt increment), molt interval, and size of hemocytes in control 
and experimental crabs.  Injections of 10 µg of CasPPO-hemo-dsRNA during 
the experiment do not affect A) molt increments: White bars = time zero; black 
bars = at the end of the experiment (~48 hrs after ecdysis); B) The molt 
intervals; and C) the size of hemocytes in the dsRNA injected crabs and 
controls. Solid bars = control group; open bars = dsRNA injected crabs. G = 







Supplemental Figure S6. The knockdown-efficiency of CasPPO-hemo-dsRNA.  
The intermolt crabs received 10 µg of CasPPO-hemo-dsRNA every other day. 
CasPPO-hemo transcripts are reduced by ~90% after the second injection, 
compared to controls that received crustacean saline.  The overall final 
knockdown efficiency after 4 injections (8 days) is ~60%. 
 
3.6.3 Supplemental Protocol 
Protocol S1. Isolation of HLS-PO activity and characterization of a rabbit 
anti-CasPPO-hemo serum (α-CasPPO-hemo) 
HLS was prepared with the hemocytes of juvenile crabs at intermolt stage, as 
described [95] and further precipitated using saturated ammonium sulfate (SAS) 
[183,184,219,220]:  SAS was added to HLS at 30% final concentration (v/v) and 
mixed on ice for 20 min by constant stirring (~1000 rpm), centrifuged at 15,000 g at 
4ºC for 20 min and then, the protein pellet was retrieved and resuspended in 50 or 100 
µl of ice-cold working buffer.  The supernatant was retrieved and was used as the 
source for subsequent ammonium sulfate precipitation at 50 and 65%.  The protein 
concentration of each SAS fraction was assayed for PO activity after the protein 




HLSs (2 µg) were separated on a 10% SDS-PAGE.  The proteins were 
transferred onto a nitrocellulose membrane (Bio-Rad) and further processed using the 
procedure as described [94].  In brief, the membrane was blocked with 7% nonfat 
milk (NFM) in PBST (1X PBS, 0.05% Tween 20) at RT for 2 hrs.  The primary 
antibody (α-CasPPO-hemo; 1: 2,000 dilutions in NFM+PBST) was incubated 
overnight at 4ºC.  After washing with PBST (three times per 20 min each), the 
membrane was then incubated with a secondary antibody, horseradish peroxidase 
(HRP) conjugated goat anti-rabbit IgG (Jackson Immuno-Research) at 1:10,000 
dilutions for 1 hr at RT.  The signals on the autoradiography film (HyBlot CL, 





Chapter 4: Does the role of bursicon in the shell-hardening 




The heterodimer neurohormone bursicon mediates the cuticle tanning of 
insects (Drosophila and Manduca) after ecdysis.  Recently bursicon has been found 
also in crustaceans and its molecular structure is highly conserved as in insects.  
Moreover, crustacean bursicon titers increase in the hemolymph peaks at the 
completion of ecdysis, suggesting its putative function in shell-hardening, similar to 
insects.  The mechanisms by which shell-hardening of crustaceans occurs are not yet 
understood.  However, the involvement of hemocytes and prophenoloxidase (PPO) in 
the sclerotization of new cuticle has been reported in several crustacean species.  Our 
earlier study shows that bursicon induces hemocyte granulation, aggregation, and 
recruitment beneath the new cuticle.  We hypothesized that hemocytes may be one of 
the target tissues of bursicon in shell-hardening and may modulate the PPO cascade 
system, possibly through regulation of hemocyte PPO and its activating enzyme 
expression.  Multiple injections of CasBurs-α and CasBurs-β dsRNA in the blue crab, 
Callinectes sapidus show the heterodimer bursicon (the active neurohormone) does 
not regulate the PPO expression of PO activity in hemocytes.  However, the injection 
of either CasBurs-α or -β dsRNA delays the shell-hardening of injected crabs.  The 
co-injections of CasBurs-α+β dsRNA do not change the normal progress of the shell-




shell-hardening process.  The exact mechanism of hormonal actions of CasBurs in 
shell-hardening process needs further studies. 
 
4.2 Introduction 
The molting process in crustaceans and all arthropods is controlled by a 
battery of hormones and ends with ecdysis, the stage when the animals shed the hard 
exoskeleton [4,6,221]  Immediately after ecdysis in crustaceans, a soft external cuticle 
is rapidly transformed in a hard exoskeleton [2] by two consecutive processes: 
sclerotization and mineralization [11,13,15,16,18,70,196].  Cuticle sclerotization, one 
of the last hormonal regulated ecdysial process, has been well studied in insects 
[11,12,17,21,219].  Bursicon (Burs) as a heterodimer protein (α and β at 1:1 ratio) that 
is produced as a ~30 kDa central nervous system hormone, controls the cuticle 
tanning and the wing expansion of many insects after ecdysis [54,56,58–61,138–
140,222].  Recently homodimers (α+α and β+β) are also found in Manduca 
[58,60,142].  While the insect heterodimer molecule is the active hormone 
responsible for insect tanning, the homodimer forms mediate the expression of 
antimicrobial peptides (AMP) during ecdysis [142]. 
The neuroendocrine regulatory mechanisms by which cuticular sclerotization 
at the postmolt stage of crustaceans occur have not been much studied.  Recently, 
bursicon has been found in several crustacean species including Callinectes sapidus, 
Daphnia arenata, Carcinus maenas, Homarus gammarus, H. americanus [62,64,65]. 
The bursicon titers in the hemolymph of C. sapidus peaks at the completion of 




those of insects.  An in vitro incubation of the late premolt cuticle with recombinant 
Burs indicates that hemocytes and hypodermis may be candidates of its target tissues 
[62].   
The pattern of expression of Burs-α and -β in crustaceans seems to be 
different from that of insects [54,62,64].  In Callinectes, a constant expression of 
CasBurs during the molt cycle can be explained by little variation of CasBurs-α.  On 
the other hand, the skewed expression of CasBurs-β is described in the ratio CasBurs-
β vs -α.  As a result, a CasBurs-β homodimer in addition to heterodimer has been 
suggested [62]. 
Hemocytes that play key roles in the innate immunity system of arthropods 
[96,115,119,147,223–225] are now thought to have an additional role in shell-
hardening in decapod crustaceans [37, Alvarez and Chung in preparation].  C. sapidus 
carries three main types of hemocytes as described [82,104,105,115,123]: 
granulocytes (Gs), semigranulocytes (SGs) and hyaline cells (Hs).  We reported that 
CasPPO-hemo [95], the hemocyte prophenoloxidase (PPO) of C. sapidus participates 
in the sclerotization of the cuticle during postmolt (Alvarez and Chung, in 
preparation).  Together with our earlier data and other reports, we hypothesized that 
CasBurs, the C. sapidus bursicon, may be involved in the shell-hardening process via 
modulating the PPO expression in hemocytes.  
In this study, we used multiple injections of CasBurs-α and -β dsRNA in C. 
sapidus juveniles that were raised in the blue crab hatchery (Aquaculture Research 
Center, IMET, Baltimore, MD).  We analyzed the levels of expression of CasBurs-α 




hemocytes, together with immunostaining of CasPPO-hemo and flow-cytometry of 
hemocytes.  The results show that multiple injections of CasBurs-α or -β dsRNA alone 
slowed the shell-hardening, although they had no effect on the levels of PPO 
expression, implicating the role of bursicon homodimer in the shell-hardening process.  
The co-injections of CasBurs-α+β dsRNAs (1:1 ratio) do not interfere the shell-
hardening process. 
 
4.3 Materials and Methods 
4.3.1 Animals 
Juvenile blue crabs C. sapidus (15-30 mm carapace wide, CW) were obtained 
from the blue crab hatchery [Aquaculture Research Center, the Institute of Marine 
and Environmental Technology (IMET), Baltimore, MD].  The animals were grown 
in tanks with individuals cages in recirculated aerated artificial seawater (25 ppt; 
22ºC) as described [62,158,159].  The water quality was monitored daily for The 
Clinical Laboratory Analysis of National Aquarium, Baltimore, MD (NAIB).  
Juvenile females and males animals with 76.7 ± 1.7 mm CW, at intermolt stage were 
used as experimental animals unless described otherwise. 
4.3.2 Effects of multiple injections of CasBurs-α and -β dsRNAs on the cuticle 
hardness and CasPPO-hemo expression in hemocytes 
4.3.2 1 In vitro transcription of CasBurs-α and -β dsRNAs 
The templates for CasBurs-α and -β dsRNAs were generated by amplification 




Purification of templates and in vitro transcription were made as described [202] 
using a TranscriptAid™ T7 High Yield Transcription kit (Fermentas).  Ten µg of 
each dsRNA were dissolved in crustacean saline solution (100 μl) contained 0.001% 
phenol red [203].  Similarly, the co-injection of CasBurs-α and -β dsRNAs (α+β) was 
prepared in a ratio 1:1 (10 µg each) [138] in 100 μl of crustacean saline and 0.001% 
phenol red. 
 
Table 5. List of primers used for dsRNA template amplification and qPCR assay 















Q = qPCR primers  ds = dsRNA   α=alpha; β=beta; 
T7 promoter sequence is italicized. 
 
4.3.2.2 Multiple injections of CasBurs-α and -β dsRNAs 
Juvenile intermolt crabs (76.7 ± 1.7 mm CW) were injected with 100 μl of 
dsRNA three times a week until ecdysis.  During this period, animals received in total 
of 22-30 injections.  Three experimental groups (n=6-7) and one control (n=7) were as 
follows: i) crabs injected with co-injection of CasBurs-α+β dsRNA (dsRNAαβ group); 




CasBurs-β dsRNA (dsRNAβ group).  The control group was injected with 100 μl of 
crustacean saline alone.  Phenol red was added to monitor the delivery on injection 
materials [203]. 
4.3.2.3 Quantification of cuticle hardness during postmolt 
After ecdysis, the cuticle hardness of each crab was measured for 48 hrs by a 
hand-held Shore-type durometer (00 gauge, Instron, USA) as described [27,46].  
Regulations of PPO expression affect the whole hardening of the cuticle through the 
initial sclerotization process.  Because the rates of hardness vary depending on the 
area of cuticle [195], the hardness of the cuticle was evaluated on the mesogastric 
area of the carapace by sampling 6-8 points (Suppl. Fig S6) as described [27,46, 
Alvarez and Chung, in preparation].  The data are shown as mean ± SE of durometer 
unit (DU) as described [195]. 
4.3.2.4 Levels of CasBurs-α and -β expression in TGC 
At the end of the experiments (48 hrs after ecdysis), crabs were placed on ice 
for 5-10 min and dissected for thoracic ganglion complex (TGC) and pericardial 
organs.  Immediately after dissection, the tissues were kept on dry ice and kept in -
80oC.  TGC and PO are known as the expression and storage tissues of bursicon, 
respectively [62].  Then, TGC was used as source of RNA for cDNA synthesis and 
pericardial organs (POs) were the source for proteins. 
The cDNA was synthesized as described [62].  Each sample cDNA was 
assayed in duplicated for expression levels of CasBurs-α and –β, using qPCR (n=6-7) 




Time PCR System (Applied Biosystem). qPCR primers are listed in Table 1. The 
standards preparation and qPCR conditions are as described [62,164].  The data are 
shown as mean ± SE copies/μg total RNA. 
4.3.2.5 Levels of CasBurs proteins 
The protein contents of pericardial organs were prepared as described [62].  
Briefly, a single pericardial organ were placed in 25 μl of lysing buffer, sonicated 
(Branson Sonifier 450) twice for 5 sec each in cold condition, and centrifuged at 15,000 
g for 20 min at 4ºC.  The supernatants were retrieved into fresh tubes and kept at -20ºC 
until further use.  Twenty five percent of a pericardial organ were loaded and separated 
by a 15% SDS-PAGE, for 4 different crabs in each treatment, and stained using 
coomassie brilliant blue staining.  For western blot, the proteins were transferred onto 
a nitrocellulose membrane (Bio-Rad) for 1 hr at constant 100 v.  Then, the membrane 
was blocked with 7% nonfat milk (NFM) in PBST (1X PBS, 0.05% Tween 20) at RT 
for 2 hrs.  The primary antibody (anti-CasBurs; 1:3,000 dilutions in NFM+PBST) [62] 
was incubated overnight at 4ºC.  After washing with PBST (three times per 20 min 
each), the membrane was then incubated with a secondary antibody, horseradish 
peroxidase (HRP) conjugated goat anti-rabbit IgG (Jackson Immuno-Research) at 
1:10,000 dilutions for 1 hr at RT.  The signals on the autoradiography film (HyBlot CL, 
Denville Scientific Inc.) were detected by chemiluminescence using luminol as a 




4.3.2.6 Levels of CasPPO-hemo expression in hemocytes 
Twenty four hrs after ecdysis, 400 μl of hemolymph were collected in an 
anticoagulant solution [95] at 1:1 ratio (v:v) and kept on ice for RNA extraction and 
hemocyte lysate supernatants (HLS) as described [41, Alvarez and Chung, in 
preparation].  One μg total RNA was subjected to cDNA synthesis using a 
PrimeScript RT Reagent Kit with gDNA Eraser for Real Time PCR (Takara 
Biotechnology).  Using qPCR assays, the levels of CasPPO-hemo expression in 
samples were assayed in duplicate, along with the standards that were prepared the 
same as described as described [95].  Primers for qPCR assay were listed in Table 5.  
The data are shown as mean ± SE copies/µg total RNA. 
4.3.2.7 Levels of CasHLS-PO activity 24 hrs after ecdysis 
Callinectes HLS (CasHLS) was obtained as described in [95].  The PO 
activity of CasHLS was evaluated by estimating the formation of dopachrome from 
L-3,4-dihydroxyphenylalanine (L-DOPA) using 15 μg of HLS (~100,000 hemocytes 
or ~11 µl of hemolymph equivalent) as described [95].  The data are shown as mean 
± SE (n=5-7) of PO activity (OD/mg HLS). 
4.3.2.8 Immunocytochemistry (ICC) of hemocytes 24 hrs after ecdysis 
Twenty four hrs after ecdysis, 100 μl of hemolymph were collected in a 
fixative (4% PFA in 10 mM cacodylate buffer) as described [95].  The levels of 
CasPPO-hemo in hemocytes were analyzed by the fluorescent intensity of the 
positive signal using a rabbit CasPPO-hemo antiserum (α-CasPPO-hemo; Alvarez 




as described by Alvarez and Chung (in preparation).  The ICC samples were pictured 
using a binocular fluorescent microscope Axioplan, Zeiss with a digital camera 
AxioCam MRc, Zeiss and the software Zen 2012 (Zeiss).  The relative staining 
intensities were analyzed using the ImageJ [204] and presented as mean ± SE of 
fluorescent intensity. 
4.3.2.9 Levels of CasPPAE expression in hemocytes 
Using qPCR assays, the levels of CasPPAE (Callinectes PPO activating 
enzyme, GenBank accession No DQ667138.1) expression in hemocytes cDNA 
samples were assayed in duplicate, along with the standards that were prepared as 
described [95].  Primers for standard preparation and qPCR assay were listed in Table 
5.  The data are shown as mean ± SE copies/µg total RNA. 
4.3.2.10 Hemocyte granularity using flow-cytometry 
Fixed hemocyte sample (as above) were analyzed by flow-cytometry.  
Hemocytes were stained with SYBR-Green I nucleic acid (FMC Bioproducts) 
staining (2X) at 1:100 ratio (v:v = SYBR-Green I:sample).  After 10 min incubation 
at RT, 40 μl of each sample were analyzed using a C6 CFlow flow-cytometer (Accuri 
Cytometers), with setting at a media fluidic rate (35 μl/min) and a core size of 16 μm 
at FSC-H, SSC-H and FL1-H.  Hemocytes types were characterized by their size 
(FSC-H) and cytosolic complexity and granularity (SSC-H).  The data are presented 





4.3.3 Statistical analysis 
The data were subjected to normality test using Kolmogorov-Smirnov test (K-
S) and the homogeneity of variances by Cochran C test (Statistica 7.0, Stat Soft., Inc).  
Statistical significance of ANOVA was accepted at P < 0.05 and post-hoc Tukey test 
was adopted to distinguish the source of variation among the molt stages.  When a 
nonparametric test was employed, a Kruskal-Wallis ANOVA with a Multiple 
Comparison of Mean Ranks was used.  The data are presented as mean ± SE (n), 
where n is the number of crabs per each experimental group.  ANCOVA analysis was 
used for shell-hardness of postmolt crabs. The ANCOVA assumptions were evaluated 
by K-S and Cochran C test. 
 
4.4 Results 
4.4.1 Effects of multiple injections of CasBurs-α and -β dsRNAs on CasPPO-hemo 
expression in hemocytes and the cuticle hardness 
4.4.1.1 Levels of CasBurs-α and -β expression and CasBrus proteins 
The multiple injection of CasBurs-α dsRNA, CasBurs-β dsRNA, and CasBurs-
α+β dsRNA reduce the levels of CasBurs-α and -β transcripts in the TGC obtained at 
48 hrs after ecdysis (Fig. 14A and S7).  The control group (n=7) shows an expression 
level of 1.1 ± 0.3 x 106 copies/µg total RNA for α and 7.3 ± 1.7 x 106 copies/µg total 
RNA for β.  In the experimental dsRNAαβ group, a significant knockdown of both α 
and β is observed (P < 0.05; n=7): α = 4.8 ± 2.8 x 103 copies/µg total RNA (~99% 




dsRNAα group (n=6) has reduced levels of α transcripts, estimated with 2.0 ± 1.2 x 
105 copies/µg total RNA (81% knockdown) and β expression of 2.0 ± 0.4 x 107 
copies/µg total RNA (175% over the control expression).  On the other hand, 
dsRNAβ group (n=5) shows levels of α, with 9.7 ± 1.1 x 106 copies/µg total RNA 
(811% over the control expression) and of β expression with1.6 ± 0.6 x 105 copies/µg 
total RNA (98% knockdown).  
4.4.1.2 The effects of CasBurs-α and -β dsRNA injections in the hardness of postmolt 
cuticle 
The cuticle hardness in each treatment is shown as in Figs. 15A-C.  Control 
group cuticle hardness increases from 25 ± 6.8 DU at 2 hrs after ecdysis to 42.9 ± 0.9 
DU at 8 hrs.  After, control cuticle reaches 61.7 ± 2.6 and 88.6 ± 0.4 at 24 and 48 hrs 
after ecdysis, respectively (n=7).  The dsRNAαβ group does not show differences in 
the hardness of the cuticle compared to controls (n=7).  The hardness of the cuticle of 
dsRNAαβ group is quantified in 25.0 ± 3.0 DU at 2 hrs after ecdysis, while dsRNAα 
and dsRNAβ groups show 18.0 ± 1.0 and 10.0 ± 4.5 DU respectively.  At 24 hrs after 
ecdysis the cuticle hardness for each experimental group is from 63.8 ± 3.2 DU 
(dsRNAαβ, n=7), 52.1 ± 3.6 DU (dsRNAα, n=6), and 53.5 ± 7.4 DU (dsRNAβ, n=5) 
increasing to 78.4 ± 4.1 (dsRNAαβ, n=7), 71.1 ± 4.5 (dsRNAα, n=6), and 69.5 ± 1.5 
(dsRNAβ, n=5) at 48 hrs after ecdysis.   
The values of HD50, the time to reach the 50% of cuticle hardening, are 
estimated at 8.3 ± 0.9 hrs for the control group (n=7).  Similar to the control, 
dsRNAαβ shows a HD50 of 7.7 ± 0.9 hrs (n=7). On the other hand, dsRNAα shows 






Figure 14. CasBurs-α and -β expression in the TGC at 48 hrs after ecdysis. A) 
A significant knockdown by the multiple injections of CasBurs-α and 
CasBurs-β dsRNAs is observed respect to the control (n = 6-7).  Open 
bars=Burs-α and close bars=Burs-β.  Asterisk represents significant differences 
(P < 0.05).  Solid line represents the ratio of CasBurs-β/α.  B) CasBurs 






Figure 15. Effects of CasBurs-α and –β dsRNA injections on the cuticle 
hardness after ecdysis (48 hrs). The hardness of the cuticle was evaluated using 
a hand-held Shore-type durometer.  Solid lines=control; dashed lines=dsRNA 
injected crabs; dot lines=HD50; short dashed line at C=HD25.  A) The 
dsRNAαβ group and control show similar hardening models (P > 0.05).  B) 
dsRNAα group shows a significant slowed shell-hardening of the cuticle (P < 
0.05).  Similar, C) dsRNAβ group significantly slows the shell-hardening 
during postmolt (P < 0.05).  At “C” the dashed-double dot line (-··-) represents 
the CasBurs-β-dsRNA injected crab which shows extended cuticle softness.  
The significant differences were estimated by ANCOVA at P < 0.05.  R2 





4.4.1.3 Effects of CasBurs-α and -β dsRNA injections on hemocyte CasPPO-hemo 
expression and CasHLS-PO activity 
The expression of CasPPO-hemo in hemocytes (24 hrs after ecdysis) does not 
show significant differences between control and CasBurs-α and –β dsRNA 
experimental groups (Fig. 16A; P > 0.05).  In the hemocytes of control animals, 
levels of CasPPO-hemo expression are measured as 2.5 ± 0.4 x 106 copies/µg total 
RNA (n=7).  Hemocytes CasPPO-hemo expression in dsRNAαβ group shows 
transcript levels of 2.2 ± 0.6 x 106 copies/µg total RNA (n=7), while dsRNAα and 
dsRNAβ have 3.2 ± 0.9 x 106 (n=6) and 3.3 ± 1.0 x 106 copies/µg total RNA (n=5) 
respectively (Fig. 16A). 
No differences were found in CasHLS-PO activities of all experimental 
groups and control (n=5-7; Fig. 16B).  The CasHLS-PO activities in each 
experimental group are 12.5 ± 1.5 OD/mg HLS (control; n=7) and 12.7 ± 3.5 OD/mg 
HLS (dsRNAαβ; n=7), 11.5 ± 2.6 (dsRNAα; n=6) and 10.0 ± 2.4 OD/mg HLS 
(dsRNAβ; n=5). 
4.4.1.4 The effects of CasBurs-α and -β dsRNA injections on CasPPO-hemo in 
hemocytes 
During postmolt, all the hemocytes show a positive staining with a rabbit-
CasPPO-hemo antiserum in all the experimental groups and control (Figs. 16C and 
17A).  The intensity of CasPPO-hemo staining is significantly reduced in the 
hemocytes of dsRNAα and dsRNAβ groups (P < 0.05; Fig. 16C).  However, the 







Figure 16. Levels of Prophenoloxidase (CasPPO-hemo) transcripts and PO 
activity from hemocytes at 24 hrs after ecdysis.  A) Expression analysis by 
qPCR. No significant differences (n.d.) are detected between control and 
experimental groups by one way ANOVA (n=5-7).  B) CasHLS-PO activity, 
no significant differences are detected by one way ANOVA (n=5-7).  C) 
Intensity of the positive signal of α-CasPPO-hemo serum staining in 




4.4.1.5 The effects of CasBurs-α and –β dsRNA injections on cytosolic complexity 
and granularity of hemocytes 
Hemocytes are grouped into three type by their size (Fig. 18A and B, FSC-H) 
and into three by cytosolic complexity and granularity (Fig. 18A and C, SSC-H).  
Three hemocyte types are distinguished based on FSC-H vs SSC-H values (Fig. 
18A): Gs with the highest SSC-H values, SGs with intermedia SSC-H values, and Hs 
with lowest SSC-H values.  The distribution of the hemocyte sizes (Suppl. Table S2) 
in all the experimental groups are similar to those of control (Figs 18A-A’; Fig. 18B).  
The granularity observed in Gs in the dsRNAαβ group is significant reduced than the 
control (P < 0.05).  For each differentiated hemocyte type in control the granularity 
values are: Gs = 22.7 ± 0.7 x 105 SSC-H, SGs = 57 .6± 0.8 x 104 SSC-H, and Hs = 
24.4 ± 0.5 x 104 SSC-H.  The granularity values in the dsRNAαβ group are:  Gs = 
19.6 ± 0.6 x 105 SSC-H, SGs = 61.6 ± 6.2 x 104 SSC-H, and Hs = 26.1 ± 1.8 x 104 
SSC-H. 
Granularity of hemocytes in dsRNAα and dsRNAβ groups (Figs. 18C) is not 
significant different (P > 0.05) respect to control.  The detected values of granularity 
in Gs, SGs, and Hs with dsRNAα and dsRNAβ groups are: Gs = ~24.1 ± 0.1 x105 
SSC-H, SGs = ~58.1 ± 0.1 x 104 SSC-H.  Hs increased their SSC-H to ~29.0 ± 0.2 x 
104. 
There are no differences in total and differential counting of hemocytes (THC 








Figure 17. CasPPO-hemo immunostaining in hemocytes collected 24 hrs after 
ecdysis using α-CasPPO-hemo serum. Representative images for each 





4.4.1.6 Effects of CasBurs-α and -β dsRNA injections on hemocyte CasPPAE 
expression 
The expression of CasPPAE in hemocytes (24 hrs after ecdysis) is reduced 
in CasBurs-α and –β dsRNA injected crabs respect to the control.  Specifically, a 
significantly reduced expression is observed (Fig. 20; P < 0.05) in CasBurs-α 




expression are measured as 4.4 ± 0.9 x 106 copies/µg total RNA (n=7).  Hemocytes 
CasPPAE expression in dsRNAαβ group shows transcript levels of 4.1 ± 1.1 x 106 
copies/µg total RNA (n=7), while dsRNAα and dsRNAβ have 2.0 ± 0.3 x 106 (n=6) 
and 2.8 ± 0.6 x 106 copies/µg total RNA (n=5), respectively (Fig. 20). 
 
4.5 Discussion 
We report in this paper that CasBurs plays a role in the shell-hardening 
process of the blue crab, specifically involving hemocytes.  Hemocytes are one of the 
target tissues of CasBurs or a putative homodimer of CasBurs-α or -β.  However, our 
data indicate that the mode of action of CasBurs, homodimer of α or β does not 
involve PPO expressed in hemocytes.   
Multiple injections of dsRNA have been used in crustaceans to define 
functions of a gene of interest [45,56; Techa and Chung, in press].  Moreover, dsRNA 
injections have been used to study the bursicon roles in insects by the co-injection of 
α+β and α dsRNA [31,138,139,226].  We executed multiple injections (22-30 
injections) of 10 ug dsRNA of CasBurs-α and -β into  crabs starting at intermolt and 
continuing to ecdysis.  Since a skewed ratio of Burs-α and -β is common in most 
arthropod species [58,62,64,65,227] and in C. sapidus, there may be  a CasBurs-β 
homodimer [62], we also injected CasBurs-α or -β dsRNA alone.  
Multiple injections of CasBurs, Burs-α, or -β dsRNA reduced the expression 
of Burs-α and -β in the TGC of all the experimental animals by ~80-90%, compared 
to controls.  In addition, remaining encoded Burs-α and -β were detected in the 




dsRNA lengthen the duration of the hardening of the cuticle at postmolt, while no 
differences were found on CasPPO-hemo expression and PO activity in hemocytes.  
Multiple injections of CasBurs dsRNA do not affect shell-hardness as  
measured by a  durometer, while CasBurs-α or -β alone slows the process, compared 
to controls [27,46, Alvarez and Chung, in preparation].  The rates of hardness vary 
depending on the area of cuticle [195] and the hardness of the cuticle was evaluated 
on several point of the mesogastric area and for 48 hrs.  
However, in dsRNAα and dsRNAβ experimental groups, all three hemocytes 
exhibit α-CasPPO-hemo immunostaining intensities lower than those of controls.  
While Gs in the dsRNAαβ group show a reduced cytosolic granularity compared to 
those of controls.  Hemocyte granules are described as enzyme-filled lysosomes [111] 
and represent an important cytoplasmic storage machinery for many proteins 
[111,209] in which enzymes and other proteins are associated with the PPO activating 
cascade system [209].  The degranulation of hemocytes, particularly Gs, is known as 
a prototypical immune reaction in response to pathogenic bacterial infection, 
indicating the exocytosis of the granule contents and cell lysis [209,217].  Low 
granularity may indicate the amounts of proteins stored in the cytosol.  All 
experimental groups injected with dsRNA show no differences in PPO expression and 
PO activity measured using an in vitro assay, implying there may be no changes in 
the content of PPO in cytoplasmic granules of the hemocytes [209,229].  However, 
the endogenous PO activity depends on the proteolytic activation of PPO by PPO 
activating enzymes (PPAEs) [26,36,230,231].  PPAEs are known components of 




(CasPPAE, GenBank accession No DQ667138.1) in hemocytes in all the 
experimental treatments using a qPCR (Fig. 7).  Interestingly, a reduced level of 
CasPPAE transcripts are observed in α and β dsRNA injected animals with respect to 
the control, although these values do not statistically differ.  Particularly, the dsRNAα 
group has significantly lower expression levels of CasPPAE than the other 
treatments. 
The reduced granularity detected in Gs in CasBurs-α+β dsRNA injected crabs, 
may indicate that Gs respond to bursicon knockdown releasing its PPO cascade 
system to support the cuticle hardening in this experimental group.  Previously, it has 
been observed SGs and Hs may have a more specific role in shell-hardening of the 
blue crab (Alvarez and Chung, in preparation).  However, Gs may support the cuticle 
hardening system with the PPO cascade system stored in its granules [111,209].  
Bursicon may mediate specific pathways during shell-hardening that are affected by 
the co-injection of α and β dsRNA resulting in the degranulation of Gs as happened in 
wound healing and cuticle repairs [232]. 
The injections of CasBur-α dsRNA are effective and reduce the levels of the 
target transcripts in experimental crabs.  However, the efficiency of knockdown 
appears to be different: control expression of α = 1.1 ± 0.3 x 106 copies/µg total RNA 
and β = 7.3 ± 1.7 x 106 copies/µg total RNA; CasBurs-α+β dsRNA 99% and 90% 
knockdown of α and β; CasBurs-α dsRNA 81% knockdown of α; CasBurs-β dsRNA 
98% knockdown of β.  The co-injection of α+β increases the knockdown efficiency of 




expression of β is enhanced ~2 folds respect to the control group.  Similarly, the 
knockdown of β affects positively the transcription of α in ~8 folds.   
 
 
Figure 18. Flow-cytometric analysis of hemocytes, 24 hrs after ecdysis in dsRNA 
injected crabs and control group (n=5-7).  Control and experimental dsRNA 
groups show similar patterns.  A-A’’’) Three hemocyte types are differentiated. 
B) The values of FSC-H, associated to cell sizes do not show significant 
differences between control and experimental groups. C) Cell granularity: 
Significant differences between control and dsRNAαβ are detected in the 
granularity of Gs (P < 0.05; n=7).  The hemocytes granularity of dsRNAα and 
dsRNAβ does not show significant differences respect to the control (two way 





Figure 19. Total (THC) and differential (DHC) hemocyte counting using flow-
cytometry.  No significant differences are detected between control and 
experimental groups (n=5-7). 
 
 
Figure 20. Callinectes sapidus prophenoloxidase activating enzyme, 
CasPPAE (GenBank accession No DQ667138.1) expression levels in 
hemocytes (n=5-7). The expression analysis was performed by a qPCR assay 
using a Fast SYBR Green Master Mix (Applied Biosystems) on a 7500 Fast 
Real-Time PCR System (Applied Biosystem). The data are expressed in mean 
± SE of copies/µg total RNA. The significant differences were analyzed by 




Skewed ratios between α and β expression levels are commonly noted in 
arthropods [64,65,227]: some species exhibit higher expression of α than β [58,64] 
and others higher expression of β than α [62,65,227].  The skewed ratios between α 
and β also suggest the presence of putative homodimers [18,25,26].  In C. sapidus, 
our previous study shows that there may be a putative CasBurs-β homodimer present 
in POs.  The function of a homodimer has not been well-defined in arthropods: 
recently in Drosophila, both α-α and β-β homodimers were found to induce the 
expression of antimicrobial peptides genes via the upregulation of NF-kappaB Relish 
transcription factor during and immediately after the ecdysis [142].  It appears that 
maintaining the inherent physiological ratio between α and β may be of great 
importance in Burs functions.  The over expression of one bursicon transcript may 
increase its translation rate and induce the formation of homodimers.   
Not all insect tanning appears to depend on the presence of bursicon 
[138,226].  In D. melanogaster, bursicon binds to LGR transduces its signal via 
cAMP [58,140,222].  Moreover, it induces the expression of antimicrobial peptides 
during the insects ecdysis, via the upregulation of transcription factors [142].  The 
presence of homodimer receptors are not known but these homodimers may have 
their own separate receptors  [58,140,142,222].  In some insects including 
Drosophila, bursicon acts on the phosphorylation of tyrosine hydroxylase (TH) and 
increases its enzymatic activity [52,91,233].  Specifically, the monophenol activity of 
TH allows the hydroxylation of tyrosine to DOPA, a required substrate for 
sclerotization and melanization of the cuticle [51,61,91].  Downstream in the 




the protein and chitin fibers in the cuticle [17,21].  In Tribolium castaneum and 
Bombyx mori, the tanning process of these species does not depend on bursicon 
[138,226].  Tribolium and Bombyx may have a sclerotization system that is 
independent of TH [138,226].  Additionally, the monophenol activity of PPO has 
been reported and proposed in the earlier step of the sclerotization system 
[11,17,21,88,234,235]. 
In Callinectes, the cuticle sclerotization system may depend on the 
monophenol activity of PPO.  The results demonstrate that the co-injections of α+β 
dsRNAs do not affect the levels of CasPPO-hemo in the experimental crabs.  
Moreover, hemocyte CasPPO-hemo that has monophenol activity [95], involves the 
shell-hardening of this species (Alvarez and Chung, in preparation). 
Additionally, the synthesis of (a) diphenol (or s) precursor for sclerotization is 
not limited to the activity of POs.  The synthesis of NAD and NBAD, precursors of 
quinones in the insect tanning process are synthesized by hypodermal cells being the 
phenol precursors for cuticle tanning in many insects [11,12]. 
The endogenous concentrations of bursicon in the hemolymph of C. sapidus 
[62], strongly support that this hormone have a physiologically important role in 
ecdysis.  Bursicon titers increase ~5 folds at the completion of ecdysis and decline 
immediately at 2 hrs after ecdysis [62].  Similar to bursicon, the crustacean 
cardioactive peptide (CCAP) and crustacean hyperglycemic hormone (CHH) increase 
at ecdysis [62].  CCAP is essential in the ecdysis behavior and timing of insect and 
crustaceans [10,161].  While CHH mediates the hyperglycemic activity, ion transport, 




these endocrine control pathways during the ecdysis have shown to be lethal for the 
animals [59,237].  We have also observed that only the animals injected with the β 
dsRNA show some mortality during the ecdysis.  This implies that the injection of β 
dsRNA may have disrupted a coordinated hormonal cascade that is required for 
successful ecdysis.  
In our laboratory, we have identified several putative target tissues of CasBurs 
by isolating partial cDNA sequences of LGR like molecule (unpublished data).  By 
using RNAi-mediated suppression of genes encoding Burs receptor, the resulting 
phenotypes may unravel the role of bursicon during ecdysis and postmolt of 
crustaceans. 
 
4.6 Supplemental Tables and Figures 
4.6.1 Supplemental Tables 
Supplemental Table S2. Differentiated cell sizes of hemocytes using flow-cytometry.  
The values are expressed as mean ± SE FSC-H x 105. No significant differences are 
observed between control and experimental groups (P > 0.05). G= Granulocytes, SG= 
Semigranulocytes, H= Hyaline cells. 
 Experimental groups G SG H 
Control 23.1 ± 0.4 21.4 ± 0.2 15.3 ± 0.2 
dsRNAαβ 26.5 ± 0.7 21.6 ± 0.3  14.3 ± 0.5 
dsRNAα 24.3 ± 0.4 22.7 ± 0.1 15.4 ± 0.0 
dsRNAβ 24.0 ± 0.3 22.7 ± 0.8 14.9 ± 0.0 







4.6.2 Supplemental Figures 
 
Supplemental Figure S7. Dorsal carapace mesogastric area of the blue crab 
(between dashed lines) and the durometer sampling points (white dots). 
 
 
Supplemental Figure S8. Preliminary data. Co-injections CasBurs-α and 
CasBurs-β dsRNA (10 µg each) in juvenile crabs (n=4). A knockdown effect on 
α and β transcripts is observed after 4 injections. Crabs were injected every 
other day during a week. A) Beta transcripts are significant (P < 0.05) 








Supplemental Figure S9. Molt related growth.  Carapace wide (mean ± SE 
CW) of crabs after ecdysis (n=6-7). Grey bars = intermolt crabs (time zero). 
Black bars = 48 hrs after ecdysis. With a similar initial size the control and 






Chapter 5:  General Discussion and future work 
 
Molting is the key process in the life history of arthropods and is essential for 
their growth, development, and reproduction.  Crustaceans undergo the first molting 
processes during embryogenesis, then embryonic molts direct the preparation of 
embryos for hatching [238–242].  After hatching, the swimming larvae undergo 
several stages, each stage is mediated by a molt that includes changes in larval 
physiology and morphology [243,244].  Next, in juvenile crustaceans the molting 
cycle permits growth and transition into adulthood.  Additionally, in many 
crustaceans the adult females only mate in the softest condition that occurs after the 
pubertal molt [1,2]. 
This dissertation focuses on the hypothesis that hemocyte PPO and bursicon 
hormone are involved in the shell-hardening of crustaceans.  The results include a 
complete description about the molecular cloning and characterization of PPO cDNA 
sequence (CasPPO-hemo, JX047321, GenBank).  Also, it included PPO expression 
and PO activity analyses during the molting cycle and RNAi experiments.  In 
addition, hemocyte differentiation and its endogenous distributions in the hemolymph 
help to define the role of hemocytes and PPO in the shell-hardening process of the 
blue crab.  Moreover, it is reported that bursicon, as a hormone candidate to involve 
the shell-hardening of crustaceans, does not upregulate PPO expression and PO 
activity.  So, the role of bursicon during the shell-hardening process of the blue crab 
is discussed.  Furthermore, it is suggested that bursicon homodimers may be involved 
in the sclerotization in crustaceans, perhaps through the upregulation of PPAEs, the 




Every molt involves synthesis of a new soft cuticle, exuviation, and hardening 
of the new soft cuticle by the shell-hardening process.  The shell-hardening process is 
an essential part of the molting cycle, because the crustacean exoskeleton protects 
against predators, offers a barrier against pathogens and body support by muscle 
attachments [1,2,245].  As a consequence, the exoskeleton is a requirement for 
mobility, defense, and feeding.  Hence, the investment in energy that each crustacean 
implements for growing throughout the molting cycle is capitalized in survival after 
ecdysis, and a hard exoskeleton maximizes the survival probabilities.  Therefore, a 
hard exoskeleton soon after ecdysis is a priority during postmolt. 
The shell-hardening process of insects has been well studied and is a reference 
for other arthropods [11,12,14,17,21].  The tanning process, which involves the 
sclerotization of cuticle proteins and melanin synthesis deposited in the cuticle, 
facilitates insect hardening.  Melanization also develops the different coloring 
observed in insects [11,12,235,246,247].  Unlike crustaceans, most insects do not 
incorporate calcium in the tanned cuticle.  However, biomineralization (i.e. deposition 
of calcium carbonate and calcium phosphate) of crustacean cuticles depends on the 
previous sclerotization, proteins in the cuticle, and chitin concentration [74–79]. 
In this study is reported Callinectes hemocytes are recruited into the 
hemolymph in a molt stage dependent manner and so is their derived PO activity.  
The hemocyte source of PPO seems to vary in different molt stages and crustacean 
species [37,82,105], this dissertation began with the assumption that all hemocytes 
may be a potential source of PPO.  If so, only a positive correlation between total 




the molting cycle.  However, this research demonstrates that all hemocyte cells do not 
contain equal quantities of PPO, and specific types of hemocytes are the source of 
PPO [95]. 
Every differentiated type of hemocyte in the blood stream of the blue crab has 
a distinct distribution during the molting cycle.  Hence, the prevalence of a specific 
group of hemocytes during one molt stage may correlate with functions of those 
hemocytes at particular period of the molting cycle.  As an example, a particular role 
is suggested for SGs and Gs during premolt, in preparation for ecdysis. On the other 
hand, a particular role of Hs is suggested during postmolt.  These suggestions are 
based on three particular findings:  i) Hs are PPO positive during postmolt, ii) They 
increase in number specifically in this stage, and iii) injections of CasPPO-hemo-
dsRNA reduce their detected PPO at postmolt. 
Using a molecular approach, the use of RNAi by the injection of specific 
CasPPO-hemo-dsRNA was found to endanger the cuticle hardening of the 
experimental crabs by the knockdown of CasPPO-hemo.  This discovery 
demonstrates that i) CasPPO is part of the sclerotization system in the blue crab and 
ii) infers the transport of the CasPPO from hemocyte into the new cuticle.  
Interestingly, the experimental results also suggest that hemocytes may have distinct 
roles during the shell-hardening process, supporting the hypothesis that Hs and SGs 
may be involved in the shell-hardening process of the blue crab. 
In decapod crustaceans, multiple injections of dsRNA have been employed to 
define the functions of a gene of interest [29,30, Techa and Chung, in press].  




immune role of PPO [132,248,249].  The suppression of PPO results in higher host 
susceptibility to pathogens [248].  The use of short-term injections of PPO-dsRNA (1 
or 2 injections) have shown the upregulation of PPO, when the animals are 
challenged by bacteria [249].  Here, apparently, the use of multiple injections of 
dsRNA to knock down CasPPO-hemo does not have an adverse on the experimental 
crabs.  Perhaps, the repeated puncturing of the experimental crabs with needles may 
positively upregulate PPO expression in some hemocytes, but not those involved in 
the shell-hardening process that contain PPO only at specific molt stages.   
It is evident that the sclerotization of the cuticle and the immune system are 
intimately related during the shell-hardening process of crustaceans.  So, a relative 
comprehensive model of the shell-hardening process may consider this relationship in 
the role of hemocytes and PPO during the progression of the cuticle hardening.  The 
sequential events included in this progression start with ecdysis, which is the result of 
interactions between a set of hormones and neurohormones [4–8]. 
Ecdysis in crustaceans begins with the increase in body volume by a regulated 
isosmotic intake of water, which provides the necessary expansion of body to split the 
old exoskeleton [1,250].  Once the exoskeleton is opened, the animals execute 
corporal movements.  Helped by corporal hydrostatic support, crustaceans release 
their limbs and body from the exuvia [1,2,251].  The pressurization of corporal 
cavities with fluid permits the development of muscle while the cuticle is soft and 
pliable [1,2,251]. 
Ecdysis may result in the mortality of many cells, as a consequence of the 




and/or ongoing growth of internal organs [1,2].  Ecdysis in insects includes apoptosis 
of cells from different tissues such as wing discs, hypodermis, and prothoracic gland, 
especially when the adult emerges [141,253,254]. 
Apoptosis activates mechanisms to clear dead cells.  These mechanisms 
depend on phagocytes [255].  In crustaceans, the immune system relies on the innate 
responses of hemocytes and AMPs [39,40].  The principal immune function of Hs is 
phagocytosis [39].  It is widely known, the role of phagocytic cells is the digestion of 
dead cells [141,253–255].  Overall, the dead cells resulting from apoptosis events in 
insect molting are phagocytized by the plasmatocytes [141,253,254], the insect blood 
cells which are the equivalent to the crustacean Hs.  Moreover, the increase of 
Callinectes Hs during postmolt and the accompanying reduction of SGs and Gs fit to 
similar patterns observed in some insect species during the final ecdysis, when the 
adults emerge [256,257].  In the blue crab Gs are the main cells that express PPO 
during the entire molt cycle.  The data support that SGs contain PPO at different molt 
stages.  During premolt these two types of hemocytes represent the maximal number 
of cells in the hemolymph, in a characteristic pattern suggesting preparation for 
ecdysis.  At ecdysis, the total number of these two hemocyte types declines.  This 
decline could be attributed to an increase in volume of the hemolymph by the 
isosmotic intake of water which allows to perform the shedding of the exoskeleton 
[1,250].  However, the abundance of Hs stays constant from premolt to ecdysis, 
suggesting the increment in plasma volume may not be the only cause that brings out 
the depletion in numbers of SGs and Gs during ecdysis.  Causes such as hemocyte 




It is a fact that crustacean hemocyte PPOs lack a signal peptide [38,44–
46,88,94,95,171–173,176]. Therefore, its release from hemocytes does not include the 
cellular secretory pathway.  Exocytosis and cell autolysis are the mechanisms of 
release [125,209,217,229].  For instance, when the immune system is threatened, Gs 
and SGs are lysed to release immune components (PPO activating system, cytokines, 
adhesive and opsonic factors) that perform the encapsulation and cytotoxic attack to 
parasites and pathogens.  Responding to the opsonic factors, Hs phagocytize the 
pathogens [119,218].  Moreover, Hs perform the clearance of dead hemocytes as 
well, during an immune reaction [119,218]. 
Arthropod immune responses are coordinated reactions that are based on 
cooperative work between the hemocyte types [40,217,258–260].  It is notable that 
insect plasmatocytes induce apoptosis of Gs in the moth Pseudoplusia includens 
[259] during encapsulation reactions.  In the coordinated and subsequent steps the 
encapsulation of parasites in the moth, a monolayer of Gs attaches to the parasites 
triggering the release of opsonic and adhesive factors.  The arrival of plasmatocytes, 
responding to these factors, contributes to the encapsulation process by layering over 
Gs and inducing their apoptosis.  As a result, the PPO activating system is released.  
Moreover, plasmatocytes release one or more factors that induce apoptosis of Gs and 
phagocytize dead Gs [259]. 
So far, there is no evidence that Hs induce apoptosis of Gs or SGs in 
crustaceans.  However, the crustacean encapsulation process has been studied in the 
past  [103,261].  One of the main reports, in the crayfish Astacus leptodactylus, 




assays [261].  The results contradict the findings in insects and report that Hs do not 
participate in the encapsulation.  Even though plasmatocytes do not form the capsule 
without Gs primary layer [262], plasmatocyte participation seems essential for 
encapsulation.  Crustacean hemocyte types do show cooperating during immune 
reactions [40,217,258], and more information about hemocyte interactions at specific 
molt stages may require future investigations, especially during the shell-hardening of 
the cuticle.  For example, investigation into peroxinectin levels during ecdysis may 
contribute to define interaction among Hs, SGs and Gs.  Peroxinectin, a known 
opsonic factor of crustacean, is released by Gs and stimulates phagocytosis by Hs 
[42].   
The distributions of hemocytes during ecdysis and postmolt of the blue crab 
suggest hemocyte autolysis may occur.  This mechanism may facilitate the release of 
PPO and other components from Gs and SGs during ecdysis as during an immune 
reaction.  On the other hand, the aggregation of hemocytes beneath the hypodermis 
during ecdysis has been associated with  cuticle sclerotization [37,38], and may 
resemble how hemocytes aggregate around parasites in the encapsulation reaction 
[40,217,258–260]. Whereas, the specific mechanisms that allow crustacean 
hemocytes to aggregate under the hypodermis have not been investigated, and it 
should be the target of future investigation.  However, PPO is positively detected in 
Hs during postmolt, and this may explain the role of Hs in the shell-hardening 
process.  In a previous chapter it was discussed that Hs infiltrate easily through the 
hypodermis to transport and deliver PPO into the new cuticle, initiating the shell-




process that has previously been reported [80,133].  The detection of PPO in Hs may 
certainly represent a dedicated role of this group of hemocytes during the shell-
hardening.  The total PPO contribution that Hs provide during postmolt exceeds 
~45% the contribution of Gs, similar to SGs, which total contribution during postmolt 
is ~42% over that of Gs contribution.  It is likely that these values of PPO 
contributions may represent the high demand for PPO during the shell-hardening 
necessary for the sclerotization of whole cuticle. 
The role of PPO in the shell-hardening process involves the mechanisms of 
enzyme activation that allow the catalytic activity of PO.  The zymogen PPO is 
converted to PO by the proteolytic action of PPAEs.  PPAEs are serine proteases that 
have been isolated from cuticles, hemolymph, hypodermis and other tissues 
[36,191,231,263–265]  PPAEs and hemocytes are coupled to the immune system, in 
response to immune challenges presented by pathogens and injuries [39,132,134].  
Hypodermal expression of PPAEs have been associated with the shell-hardening 
process, and function to activate PPO for sclerotization during postmolt in the new 
cuticle [263]. 
The PPAEs are trigged for PPO activation as an immune response in a 
cascade system called the PPO activating system [39,132,134].  The activation of this 
cascade is a result of the recognition of foreign molecules that are components of 
bacteria, fungi and parasites [39,132,134].  The activation of PPO into PO is precisely 
regulated, perhaps due to sclerotization and melanization involved in the production 
of cytotoxic quinones [80].  Many proteins are involved in the control of this cascade, 




PPO for sclerotization.  For example, sclerotization is necessary for the process of 
wound healing together with melanization [232,267–269].  Therefore, similar 
triggering mechanisms of PPAEs in the activation of PPO during the shell-hardening 
at postmolt may be expected.   
Serine protease inhibitors modulate the action of PPAEs [89], pacifastin, a 
protease inhibitor isolated from the hemolymph of the crayfish Pacifastacus, 
specifically inhibits PPAEs [270–272].  Reduced levels of pacifastin results in 
elevated melanization capacity [273].  Examination of the pacifastin levels during the 
molt cycle may provide valuable information correlated to PPO activation during the 
hardening of the cuticle.  On the other hand, the ubiquitous expression of PPAEs 
[Chung, personal communication] may suggest that they are not limited elements in 
the process of control and modulation of PPO activities.  Thus, the control on the PO 
activity may include the upregulation of PPO expression and translation.  Constant 
levels of CasPPO-hemo transcripts have been observed during the molt cycle of 
Callinectes [95], but little is known about the translation rate and half-life of the 
protein. 
PO inhibitors have also been identified in arthropods and downregulate the 
activity of POs by the formation of a protein complex [230].  Not much is known 
about these molecules in crustaceans.  
Cuticle sclerotization is a complex system that includes many POs [11,21].  
Hemocytes are the main known source of PPO [46,93–95,182,274].  Even though 
there is limited information in crustaceans, the expression of PPOs in other tissues 




in the hypodermal cells has been found in insects [87,180].  In crustaceans, it is 
possible that many PPOs participate in the sclerotization process of the cuticle.  
Evidence that the Callinectes hypodermis may express a PPO during a specific and 
short period of premolt (data not shown) supports the view that the Callinectes shell-
hardening process may also include PPOs that are not expressed in hemocytes. 
All events during postmolt describe a synchronized and progressive sequence 
that suggests the shell-hardening process may be hormonally regulated.  Testing the 
hypothesis that the bursicon hormone involves the endogenous changes observed in 
hemocytes and its PO activity, contributes to define the unknown regulatory elements 
of the shell-hardening of crustaceans.  
Bursicon is a neurohormone that mediates the events of tanning, wing 
expansion, and apoptosis of wing epidermis and abdominal ganglion during ecdysis 
and postmolt in insects such as D. melanogaster and M. sexta [58,59,61,65,141,275].  
Moreover, the pupal ecdysial behavior in Drosophila is controlled by bursicon 
[139,276,277].  Even though the presence of the hormone has been described in 
crustacean species such as D. arenata, C. maenas, H. gammarus, H. americanus, and 
C. sapidus [62,64,65], little is known about its functions in this group of arthropods.  
Crustacean bursicon is maintained in low titers in the hemolymph during the majority 
of the molting cycle and increases during ecdysis [62].  Therefore, it is likely that 
bursicon has a role during crustacean ecdysis and postmolt.  
This dissertation reports the use of dsRNA injections to define whether 
bursicon upregulates PPO in hemocytes and the shell-hardening process in the blue 




hardening and ecdysis.  In Drosophila and Manduca, the cuticle tanning depends on 
bursicon upregulation.  However, in some insects the cuticle tanning process may be 
independent of bursicon.  Studies on the red flour beetle, T. castaneum, and the 
silkworm, B. mori, show that bursicon is not required for cuticle tanning, but is for 
wing expansion [138,226].  It is possible that bursicon may involve different 
functions in diverse group of insects [56], and other arthropods as crustaceans.   
Bursicon mediates the phosphorylation of TH, which is necessary for the 
activation of this enzyme, in Drosophila and Manduca [61,222,278].  The 
monophenol activity of TH allows the hydroxylation of tyrosine to DOPA, a required 
substrate for downstream activity in the sclerotization and melanization of the cuticle 
[51,61,91].  Perhaps in Callinectes, the cuticle sclerotization system is based on the 
monophenol activity of PPO and does not rely on TH activity.  CasPPO-hemo has 
shown monophenol activity in in vitro assay [95].  It would be interesting to 
determine whether TH also participates in the shell-hardening process of crustaceans. 
It is peculiar that the injection of either CasBurs-α or CasBurs-β dsRNA does 
delay the shell-hardening process in Callinectes.  When one Burs subunit is knocked-
down, the other enhances its expression and it is suggested that the bursicon 
homodimer is formed during these experiments.  Bursicon homodimers (α-α and β-β) 
are described in insects [54,140,142].  Moreover, α recombinant bursicon has shown 
to freely form a homodimer [62].  The results suggest bursicon homodimers may be 
involved the shell-hardening of C. sapidus.  It is necessary that further investigations 
determine the role of bursicon homodimers in crustaceans.  However, it is suggested 




be interesting to know the effects that injections of recombinant bursicon homodimers 
have on the shell-hardening process of crustaceans.  Additionally, further approaches 
to investigate the role of bursicon in crustaceans should include the bursicon receptor, 
which is encoded in insects by the rickets gene (rk) [58,140]. 
Perhaps the motor-control of the shell-hardening process in some arthropods 
is based on mechanisms such as controlling the supply of the reactive components 
necessary for sclerotization.  This mechanism has been suggested previously in 
insects [11] and may include the control of transporting or restraining the synthesis of 
phenolic precursors for sclerotization.  It is well-known that the color (and likely the 
hardness) of the insect cuticle depends on the reactive phenol precursor incorporated 
into the cuticle for sclerotization [11,12].  NADA and NBAD are phenol substrates in 
almost all insect cuticles.  Insect cuticles rich in NADA are straw colored or colorless, 
while the cuticle with a dominant proportion of NBAD results in a dark brown color 
[11,235,246].  A selective allocation and distribution of the phenol substrates into the 
cuticle for sclerotization occurs in insects and it possible in crustaceans. 
The insect hypodermal cells can synthesize some of these reactive precursors.  
For example, the hypodermal cells of Locusta migratoria and Schistocera gregaria 
synthesize NADA [12].  However, it is possible other cells may participate in this 
synthesis, such as hemocytes and fat body cells (equivalent to hepatopancreas in 
crustaceans) [11,247].  It is likely that the hypodermal cells may possess a system of 
transporters that control the quantity of reactive precursors allocated into the cuticle 
for sclerotization [11].  This type of mechanism may apply to the initial pre-ecdysis 




occurs before ecdysis in C. maenas [18].  Furthermore, the observation that 
hemocytes aggregate beneath the hypodermis at early premolt implies an active 
transport of PPO [38], and the transport of reactive precursors is likely occurred 
during this period of the molting cycle. 
Is it possible that the transport or synthesis of phenol substrates in the 
hypodermis is hormonally controlled?  Indeed, it may be hormonally regulated.  An 
example is the balance between ecdysteroids and molt-inhibiting hormone addresses 
the preparation for the ecdysis in crustaceans [4–8,10,279].  As a result, the mitotic 
rates in hypodermal cells increase and these cells are initiated to secrete the new 
cuticle, and the activation of many genes occurs [6,189,280–282]. 
In summary, hemocytes show endogenous changes in their number and 
content of PPO at different molt stages.  The knockdown of CasPPO-hemo supports 
that hemocyte PPO is involved in the shell-hardening of the blue crab at postmolt.  
Future research is needed to further define the transport of PPO through the 
hypodermis to the cuticle.  The role of bursicon in crustacean cuticle hardening still 
remains to be defined; it is suggested that this hormone does not directly modulate 
PPO expression and PO activity that are required in the shell-hardening process.  
However it may involve in other components of the PPO cascade system.  
Additionally, it is necessary to investigate the role of bursicon homodimers in shell-
hardening process of crustaceans. 
This dissertation is a complement and a contribution to knowledge and the 
understanding of the shell-hardening process of crustaceans.  It opens new hypotheses 




components of innate immunity are involved in the shell-hardening process of C 
sapidus.  The links between the shell-hardening and the immune system allow us to 
explore the evolutionary origin of the hard exoskeleton of arthropods.  An early 
development of PPOs is considered in the evolution of the superfamily of 
hemocyanin proteins [20,283,284].  It has been suggested the development of PPOs 
could have a protective role in capturing the dioxygen molecule and its highly 
reactive derivatives, after the atmospheric levels of oxygen rose due to the increase in 
photosynthesis [20].  This new PO activity was surely an advantage to fix oxidative 
radicals and used as immune defense by developing biological pigments such as 
melanin [20,283,284].  As a consequence a hard exoskeleton could have originated 
through the construction of a cross-linked protein network that later could allow the 
deposition of mineral materials from the seawater.  This hard structure may provide 
better protection and mobility by muscle attachment to earlier arthropods.  However, 
the fact that a hard exoskeleton limits continuous growth, is resolved through the 








1. Preliminary experiments for the evaluation of PO activity in hemocytes, plasma 
and hypodermis 
1.1 Source of PO activity in the hemolymph of the blue crab 
Hemolymph (500 μl) from crabs at intermolt stage was collected directly into 
a syringe containing a crab anticoagulant solution (450mM NaCl, 10mM KCl, 
100mM  Glucose, 10mM NaHCO3, 10mM EDTA, 10mM HEPES, pH 7.3) in a ratio 
1:1 (v:v).  The samples were kept on ice and centrifuged at 800g for 10 min at 4ºC for 
hemocyte and plasma separation.  The hemocytes were washed twice in 200 µl of 
sodium cacodylate (10 mM) by centrifugation as above.  Plasma was retrieved in a 
new tube and kept on ice. The hemocytes were sonicated in 25 μl of working buffer 
(10 mM sodium cacodylate, 5 mM calcium chloride, pH 7.1) and then centrifuged at 
15,000g for 20 min at 4ºC.  The protein concentration of the supernatant as HLS and 
plasma were estimated using a Pierce 660 nm kit (Bio-Rad). 
The CasHLS-PO and plasma-PO activities were determined by measuring the 
formation of dopachrome from L- 3,4 dihydrophenylalanine (L-DOPA) using a 
modified assay as described [46,168,169].  Briefly, HLS and plasma samples (45 μg 
HLS or plasma in 50 μl working buffer) were preincubated with 50 μl of trypsin (1 
mg/ml working buffer) for 15 min at 37ºC.  Subsequently, 100 μl L-DOPA (3 mg/ml 
working buffer) were added and further incubated for 20 min at 37ºC.  At the end of 
20 min incubation, the samples were diluted with 150 μl of working buffer and placed 




490 nm.  The experiment also included the estimation of PO activity using the 
hemolymph (plasma + hemocytes; 45 μg hemolymph in 50 μl working buffer). 
The PO activity was calculated as OD/mg protein/ml of hemolymph and 
presented as mean ± SE (n = 3). 
Hemocytes are the main source of PO activity in the hemolymph of intermolt 
blue crabs.  A significant (P < 0.05; one way NOVA) higher activity has detected in 
HLS than the plasma and whole hemolymph. 
 
 
Figure 21. Source of PO activity in the hemolymph of the blue crab at intermolt 
stage. HLS is the main source of PO activity in the hemolymph of the blue crab 













































1.2 Kinetic characterization of CasHLS-PO activity 
The values of Km and Vmax of CasHLS-PO activity were determined with L-
DOPA as a substrate with final concentrations at 0.57, 1.125, 2.25, 4.50, and 9.0mM. 
The values of Km and Vmax were estimated using a nonlinear regression of the 
Michaelis-Menten plot using CurveExpert 1.4. 
The changes in CasHLS-PO activity are noted in the values of Vmax and Km 
during the molt cycle (Fig. 6). The lowest values of Vmax is observed with 
hemocytes at ecdysis (101.9 ± 17.5 OD/min/mg HLS), while the highest is observed 
at late premolt (174.1 ± 29.8 OD/min/mg HLS) followed by intermolt (147.5 ± 25.3 
OD/min/mg HLS). However, they show no statistical differences. On the other hand, 
a significant variation of the values of Km is noted with hemocytes obtained at 
ecdysis, compared to those measured at late premolt and postmolt (Table 2, P = 0.03). 
The values of Km of CasHLS-PO activity remain constant at intermolt, early premolt, 
late premolt, and postmolt molt stages: 3.6 ± 0.8, 2.5 ± 0.4, 2.1 ± 0.7, and 1.3 ± 0.3 








Figure 22. A) Michaelis-Menten plot and the changes in the values of Km and 
Vmax of PO activity of CasHLS during the molt cycle. B) Lineweaver–Burk 
plot of enzyme kinetic. Kinetics of PO activity was measured using L-dopa as a 
substrate. The reaction rate is expressed as delta ∆OD/min/ mg of HLS protein. x 




















































1.3. Hypodermis PO activity during the molt cycle 
The hypodermis-PO activity was determined by measuring the formation of 
dopachrome from L- 3,4 dihydrophenylalanine (L-DOPA) using a modified assay as 
described [46,168,169]. Briefly, hypodermis sections of 1.28 ± 0.66 mg were 
collected from the dorsal carapace of crabs at different molt stages.  Next, 20 μg of 
hypodermis total proteins in 50 μl working buffer were preincubated with 50 μl of 
trypsin (1 mg/ml working buffer) for 15 min at 37ºC. Subsequently, 100 μl L-DOPA 
(3 mg/ml working buffer) were added and further incubated for 20 min at 37ºC.  At 
the end of 20 min incubation, the samples were diluted in 150 μl of working buffer, 
and placed into a 96-well plate in triplicate (100 μl/well).  The absorbance was 
measured at 490 nm.  The PO activity was calculated as OD/mg protein and presented 
as mean ± SE (n = 12). 
The maximal PO activities in the hypodermis were detected at late premolt 
(0.31 ± 0.07 OD/mg of protein) and ecdysis (0.22 ± 0.09 OD/mg of protein).  The 
lower PO activity was detected at postmolt (0.10 ± 0.03 OD/mg of protein).  No 
significant differences in hypodermis PO activity during the molt cycle were detected 






Figure 23. Hypodermis PO activity during the molt cycle of the blue crab. No 
significant differences of the hypodermis PO activity are detected during the 
molt cycle using L-DOPA as substrate (one way ANOVA, P > 0.05).  Protein 
were isolated from hypodermis sections of 1.28 ± 0.66 mg collected at different 
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